Hemostasis valves and methods of use

Description

BACKGROUND

During a surgical procedure, a portion of a patient's body (e.g., vasculature) is accessed to allow for performance of a desired intervention or treatment. During such surgical procedures, it is desired to minimize patient blood loss, prevent delivery of air into the vasculature, and to maintain the sterility of the accessed portions or sites of the patient's body so as to prevent issues such as infection. Further, the desire for improved patient outcomes has led to the development of hemostasis valves that facilitate minimally invasive surgery.

In minimally invasive surgery, small incisions are created through a blood vessel which one or several catheters are inserted. Each of these one or several catheters can define a lumen extending longitudinally through that catheter. These catheters are moved to a position proximate to tissue, nerves, or other body structures targeted by the surgery, and then tools for performing the procedure are inserted through the lumens of some or all of these catheters.

To minimize blood loss, prevent delivery of air into the vasculature, and to facilitate maintenance of sterility within the patient's body (e.g., blood vessel), these catheters are equipped with hemostasis valves. These valves seal or selectably seal the lumens of the catheters. In many instances, these valves can seal the lumen of the catheter when a tool extends through the catheter, and specifically through the valve. Additionally the valves can seal the lumen when a tool is removed or does not extend through the catheter.

While such traditional hemostasis valves are greatly beneficial for intravascular access, they have some drawbacks. For example, some valves may not seal adequately for all interventional applications or tools, and/or the operation of some valves may be complicated for operator use. The drawbacks of such valve designs may in turn increase the complexity of any surgery performed therewith and/or reduce patient safety (e.g., bleeding, infection, and/or other detrimental complications). Accordingly, new and improved hemostasis valves and methods of use are desired.

SUMMARY

The following relates to valves, medical systems incorporating valves, and methods of using the same. The valve can include a tubular member that can be constricted, collapsed, and/or sealed by one or several tensioning mechanisms. The tensioning mechanism can include at least one filament that extends around at least a portion of the tubular member. The filament can interact with the tubular member to constrict, collapse, and/or seal the tubular member via manipulation of the tensioning mechanism(s). A tool can be inserted through the valve to gain access to a patient's body and specifically to gain access to a blood vessel. Through the use of the tensioning mechanism and filament to constrict, collapse, and/or seal the tubular member, the valve can seal around a wide range of tool sizes and shapes, as well as multiple tools of differing sizes simultaneously. Additionally, such a valve creates a robust seal that maintains its seal when a vacuum is applied such as occurs during aspiration.

Aspects of the present disclosure relate to a hemostatic valve for sealing a medical device. The hemostatic valve includes an elongate member having a first end, a second end, and a central lumen extending therebetween. In some embodiments, the elongate member is pliable. The hemostatic valve can include a reinforcement structure extending along at least a portion of the elongate member, such that the reinforcement structure is coupled to the elongate member. The hemostatic valve includes an active tensioning mechanism coupled to the elongate member. In some embodiments, the tensioning mechanism is moveable between a first configuration in which the central lumen is constricted and sealed and a second configuration in which the central lumen is open. Optionally, the valve may be manually adjusted by the user to intermediate positions between fully open and fully closed. Additionally, an instrument (e.g. catheter) may provide an intermediate position where the valve creates hemostasis without user adjustment.

In some embodiments, the elongate member can be a compliant polymer tube. In some embodiments, the tensioning mechanism can include at least one filament extending at least partially around the elongate member. In some embodiments, the reinforcement structure is positioned between the at least one filament and the elongate member. In some embodiments, the reinforcement structure can be a braided mesh. In some embodiments, the reinforcement structure is coupled to the elongate member at a position proximate to the first end of the elongate member and at a position proximate to the second end of the elongate member. In some embodiments, the reinforcement structure is not coupled to the elongate member at a position between the first end of the elongate member and the second end of the elongate member. In some embodiments, the central portion of the compliant polymer tube that is constrained or collapsed by the tensioning mechanism, and at least one filament, is not coupled to the reinforcement structure.

In some embodiments, the tensioning mechanism can include an actuator coupled to the at least one filament. In some embodiments there are two tensioning mechanisms coupled to the at least one filament that operate in opposite directions. In some embodiments the two tensioning mechanisms are attached to the same filament. In some embodiments the two tensioning mechanisms are attached to opposing filaments. In some embodiments, the actuator can be moveable to control movement of the at least one filament from a first position in which the central lumen is constricted and sealed to a second position in which the central lumen is open. In some embodiments, the at least one filament is in the first position when the tensioning mechanism is in the first configuration. In some embodiments, the actuator is biased towards the first position. In some embodiments, the actuator is biased toward the second position. In some embodiments, the actuator can be a manual actuator.

In some embodiments, the at least one filament forms a loop around the elongate member. In some embodiments, the at least one filament forms a bight around a portion of the elongate member. In some embodiments, the at least one filament can include a first filament and a second filament. In some embodiments, each of the first filament and the second filament are coupled to the same actuator. In some embodiments, each of the first filament and the second filament are coupled to different actuators. In some embodiments, the first filament and the second filament are moveable from the first position to the second position. In some embodiments, each of the first filament and the second filament form a loop around the elongate member. In some embodiments, the first filament forms a first bight around a first portion of the elongate member, and the second filament forms a second bight around a second portion of the elongate member. In some embodiments, the first bight extends through the second bight.

In some embodiments, the hemostatic valve can include a shell defining a first aperture and a second aperture. In some embodiments, the elongate member extends from the first aperture to the second aperture and fluidly couples the first aperture and the second aperture. In some embodiments, the tensioning mechanism is self-adjustable to seal around tools of different sizes extending through the hemostatic valve. In some embodiments, the central lumen can comprise a single lumen, and in some embodiments, the central lumen can comprise a plurality of lumens.

One aspect of the present disclosure relates to a delivery system for intravascular access of a blood vessel within a patient's body. The delivery system includes a catheter having a first end, a second end, and a catheter lumen extending therebetween and a hemostatic valve coupled to the first end of the catheter. The hemostatic valve includes a tubular member having a first end, a second end, and a central lumen extending therebetween. In some embodiments, the central lumen of the tubular member is fluidly coupled with the catheter lumen. The hemostatic valve includes an active tensioning mechanism coupled to the tubular member, the tensioning mechanism can be moveable between a first configuration in which the tensioning mechanism constricts on the central lumen and the central lumen is sealed and a second configuration in which the central lumen is open.

In some embodiments, the hemostatic valve further includes a reinforcement structure extending along at least a portion of the tubular member. In some embodiments, the reinforcement structure is located between the tensioning mechanism and the tubular member. In some embodiments, the reinforcement structure can be a braided mesh. In some embodiments, the reinforcement structure is coupled to the tubular member at a position proximate to the first end of the tubular member and at a position proximate to the second end of the tubular member. In some embodiments, the reinforcement structure is adhered to the tubular member at the first end of the tubular member and at the second end of the tubular member. In some embodiments, the reinforcement structure is uncoupled to the tubular member between the first end of the tubular member and the second end of the tubular member.

In some embodiments, the tensioning mechanism can include at least one filament extending at least partially around the tubular member. In some embodiments, the tensioning mechanism can include an actuator coupled to the at least one filament. In some embodiments, moving the tensioning mechanism from the first configuration to the second configuration can include moving the actuator and the thereto coupled at least one filament from a first position to a second position. In some embodiments, the filament constricts and seals the central lumen of the tubular member when the filament is in the first position.

In some embodiments, the actuator can be a manual actuator. In some embodiments, the actuator can include a pair of opposing and depressable buttons, which buttons can be biased towards an undepressed position. In some embodiments, the central lumen is sealed when the buttons are in the undepressed position. In some embodiments, the filament can be a monofilament. In some embodiments, the filament can be at least one of: a polymer filament; or a metallic filament. In some embodiments, the catheter can include a thrombus extraction device.

One aspect of the present disclosure relates to a method of sealing a delivery device accessing a blood vessel of a patient. The method includes inserting the delivery device including a catheter and a hemostatic valve into the blood vessel of the patient. In some embodiments, the catheter can have a first end, a second end, and a catheter lumen extending therethrough. In some embodiments, the hemostatic valve can be coupled to the first end and can have a tubular member defining a central lumen fluidly coupled with the catheter lumen and a tensioning mechanism coupled with the tubular member. In some embodiments, the tensioning mechanism collapses and seals the central lumen in a first configuration and thereby seals access to the blood vessel. The method can include moving the tensioning mechanism of the hemostatic valve to a second configuration. In some embodiments, the central lumen is open and access to the blood vessel is unsealed when the tensioning mechanism is in the second configuration. The method can include advancing a shaft of a tool through the delivery device until a first end of the tool reaches a desired position within the blood vessel of the patient and a portion of the shaft is positioned within the central lumen of the tubular member. The method can include returning the tensioning mechanism of the hemostatic valve to the first configuration such that the tubular member collapses on the shaft of the tool and seals around the shaft of the tool.

In some embodiments, the method includes retracting the shaft of the tool from the delivery device. In some embodiments, the tensioning mechanism is maintained in the first configuration during and after the retracting of the shaft of the tool from the delivery device. In some embodiments, the tensioning mechanism is moved to the second configuration during the retracting of the shaft of the tool from the delivery device, and the tensioning mechanism is returned to the first configuration after the shaft of the tool is retracted from the delivery device.

In some embodiments, the tensioning mechanism can include at least one filament extending at least partially around the tubular member. In some embodiments, the at least one filament collapses the tubular member when the tensioning mechanism is in the first configuration. In some embodiments, the at least one filament circumferentially constricts the tubular member to collapse the tubular member when the tensioning mechanism is in the first configuration. In some embodiments, the hemostatic valve can include a reinforcement structure located between the at least one filament and the tubular member.

In some embodiments, the at least one filament forms a loop around the elongate member, and moving the tensioning mechanism from the second configuration to the first configuration reduces a size of the loop to thereby constrict the tubular member within the loop. In some embodiments, the filament forms at least one bight around a portion of the elongate member. In some embodiments, the filament can include a first filament and a second filament. In some embodiments, the at least one bight can include a first bight oriented in a first direction and formed by the first filament and a second bight oriented in a second direction and formed by the second filament. In some embodiments, the first and second bights overlap to encircle a portion of the tubular member within a constricting area.

In some embodiments, moving the tensioning mechanism from the second configuration to the first configuration can include moving the first bight in the first direction and the second bight in the direction to reduce the size of the constricting area and collapse and seal the central lumen of the tubular member. In some embodiments, the tensioning mechanism can include an actuator. In some embodiments, moving the tensioning mechanism to the second configuration can include manipulating the actuator. In some embodiments, the method includes applying a vacuum to the delivery device and/or delivery system to aspirate material through the catheter. In some embodiments, the central lumen remains sealed during the aspiration. In some embodiments, the tool can include a thrombus extraction device.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of one embodiment of a delivery device.

FIG. 2 is a side-section view of one embodiment of a hemostasis valve in a first configuration.

FIG. 3 is a side-section view of one embodiment of the valve in a second configuration.

FIG. 4 is a side-section view of one embodiment of the valve in the first configuration and with a tool extending through the valve.

FIG. 5 is a side-section view of one embodiment of a single-button hemostasis valve in a first configuration.

FIG. 6 is a perspective view of a filament of a valve forming a loop.

FIG. 7 is a perspective view of two filaments of a valve, each of the filaments forming a loop.

FIG. 8 is a perspective view of two overlapping and interlocked bights in an open configuration.

FIG. 9 is a perspective view of two overlapping and interlocked bights in a closed configuration.

FIG. 10 is a flowchart illustrating one embodiment of a method for sealing a valve and/or catheter.

FIG. 11 is a side view of one embodiment of a thrombectomy system including the delivery device.

FIG. 12 is a side-section view of another embodiment of a hemostasis valve having two-piece caps.

DETAILED DESCRIPTION

The present disclosure relates to a valve that can be used a hemostasis valve. This valve, also referred to herein as a garrote valve can seal with or without a tool extending through the valve. The garrote valve provides convenient, single-handed operation for a wide range of medical devices including catheters, wires, embolectomy systems, or the like. This single-handed operation of the garrote valve allows the user to easily and quickly swap different tools being used through the valve without compromising hemostasis and therefore simplifying the procedure. Combined with single-handed operation, the garrote valve provides robust sealing either with or without a tool extending through the valve. This robust sealing minimizes leakage in applications with a pressure differential on different sides of the valve. This pressure differential can arise, for example, during the application of vacuum aspiration in a procedure. Even under such conditions, as well as under other conditions, the garrote valve maintains seal integrity and prevents leakage in one or both directions.

The garrote valve includes a tubular member. The tubular member is a flexible member that defines a central lumen, which can, in some embodiments, define a single lumen, and in some embodiments, defines a plurality of lumens. In some embodiments, each of the plurality of lumens can comprise the same size and shape, and in some embodiments, some or all of the plurality of lumens can comprise different sizes and shapes. In some embodiments, for example, the plurality of lumens can comprise a lumen sized and/or shaped to receive a guide wire and a lumen sized and/or shaped to receive a tool. The tubular member extends at least partially through a constricting mechanism. The constricting mechanism can be moved from a first configuration to a second configuration, and the constricting mechanism can collapse and/or seal the central lumen of the tubular member when the constricting mechanism is in the first configuration. The constricting mechanism creates the above-discussed robust seal of the tubular member and thus of the valve.

With reference now to FIG. 1, a perspective view of one embodiment of a delivery system 100, also referred to herein as a delivery device 100, is shown. The delivery system 100 can include a catheter 102 and a garrote valve 104, also referred to herein as valve 104. The catheter 102 can comprise a shaft 106, also referred to herein as an elongate sheath 106, having a proximal end 108, also referred to herein as a first end 108, that can connect to the valve 104 and a distal end 110, also referred to herein as a second end 110. The shaft 106 can define a catheter lumen 112 extending from the proximal end 108 of the shaft 106 to the distal end 110 of the shaft 106. The catheter 102 and specifically the shaft 106 can comprise a variety of shapes and sizes and can be made from a variety of materials. In some embodiments, the catheter 102 can be flexible and/or can be made from a biocompatible material. The elongate sheath 106 can have an outer diameter of at least 4 French, at least 6 French, at least 8 French, at least 10 French, at least 12 French, at least 14 French, at least 18 French, at least 20 French, at least 22 French, between 4 French and 30 French, between 8 French and 24 French, between 12 French and 20 French, and/or any other or intermediate size.

The valve 104 can include an outer shell 114. The outer shell 114 can comprise a variety of shapes and sizes and can be made from a variety of materials. In some embodiments, the outer shell 114 can be made from one or several polymers or composites. The outer shell 114 can include features that allow interaction with and/or control of the valve 104 to move the valve 104 between the first configuration and the second configuration.

The outer shell 114 can include a proximal cap 116 located at a proximal end 118 of the outer shell 114 and a distal cap 120 located at a distal end 122 of the shell 114. The proximal cap 116 can include and/or house a proximal aperture 124, also referred to herein as a proximal channel 124, a first channel 124, or a first aperture 124, that extends through the proximal cap 116, and the distal cap 120 can include and/or house a distal aperture 126, also referred to herein as a distal channel 126, a second channel 126, or second aperture 126, that extends through the distal cap 120. As seen in FIG. 1, the distal cap 120 connects to the shaft 106 of the catheter 102 at the distal end 122 of the valve 104.

The proximal cap 116 and the distal cap 120 are connected via a housing 128. The housing 128 can be a one-piece housing 128 or a multi-piece housing 128. In the embodiment depicted in FIG. 1, the housing comprises a two-piece housing 128. The housing 128 can be configured to receive and couple with each of the proximal cap 116 and the distal cap 120, and as seen in FIG. 1, the housing 128 is coupled with each of the proximal cap 116 and the distal cap 120 to secure the relative position of the proximal cap 116 and the distal cap 120 with respect to each other.

The housing 128 can define an interior channel 130 through which an elongate member 132, also referred to herein as a tubular member 132, a septum 132, or a tubular septum 132, can extend and connect the proximal cap 116 and the distal cap 120. The elongate member 132 can comprise a variety of shapes and sizes and can be made from a variety of materials. In some embodiments, the elongate member 132 can comprise a compliant tubular structure that can be, for example, a thin-walled compliant tubular structure. The thin-walled structure of the elongate member 132 can facilitate the collapse, and specifically the uniform collapse of the elongate member 132 and the sealing of the elongate member 132. In some embodiments, the elongate member 132 is an elastic, resilient material that may comprise a polymer including either a natural or synthetic polymer. In some embodiments, the elongate member can comprise an elastic, resilient material that may comprise silicone, urethane, ethylene-vinyl acetate, natural or synthetic rubber or other elastomers known in the art. In some embodiments, the elongate member 132 can comprise a silicone tube.

The elongate member 132 can comprise a proximal end 134, also referred to herein as a first end 134, that can couple to the proximal cap 116, and a distal end 136, also referred to herein as a second end 136, that can couple to the distal cap 120. The elongate member 132 can define a central lumen 138 that can extend from the first end 134 to the second end 136 of the elongate member 132. The elongate member 132 can be coupled to the proximal cap 116 such that the central lumen 138 is fluidly coupled with the proximal aperture 124 of the proximal cap 116, and the elongate member 132 can be coupled to the distal cap 120 such that the central lumen 138, as seen in FIG. 2 and in FIG. 3, is fluidly coupled with the distal aperture 126 of the distal cap 120.

The central lumen 138 of the elongate member 132 can be defined by a wall of the elongate member 132 that can have a thickness that is uniform along the length of the elongate member 132 between the first end 134 and the second end 136, or that is non-uniform along the length of the elongate member 132 between the first end 134 and the second end 136. In some embodiments, the wall can have a thickness that is approximately between 0.005 inches and 0.05 inches, and/or approximately between 0.010 inches and 0.030 inches. As used anywhere herein, “approximately” refers to a range of +/−10% of the value and/or range of values for which “approximately” is used.

In some embodiments, the elongate member 132 can be cylindrically shaped, and specifically can be circular-cylindrically shaped. In some embodiments, the elongate member 132 can be dog-bone shaped to facilitate, for example, connection to each of the proximal cap 116 and the distal cap 120. In some embodiments, the elongate member 132 can include one or several outward-extending protuberances that engage with all or portions of a constricting mechanism 141, also referred to herein as a tensioning mechanism 141, of the valve 104 to secure a position of all or portions of the constricting mechanism 141 with respect to the elongate member 132. In some embodiments, the constricting mechanism 141 can be self-adjusting to seal around tools of different sizes extending through the valve 104.

The constricting mechanism 141 can, in some embodiments, collapse and seal the elongate member 132 via compression and/or constriction, and specifically via constriction with at least one filament 150. The constricting mechanism 141 can comprise: an actuator 142 which can be a manual actuator such as one or several buttons 144; and the at least one filament 150 that can extend at least partially around the elongate member 132. In some embodiments, the use of the constricting mechanism 141 can facilitate sealing of the valve around tools or instruments of a wide range of sizes and/or diameters, and particularly around tools or instruments that fit through the elongate member 132.

The housing 128 can further include one or several retention features 140. The one or several retention features 140 of the housing can engage with and retain all or portions of the constricting mechanism 141 of the valve 104. In some embodiments, the one or several retention features 140 of the housing 128 can retain the actuator 142 and/or can couple the actuator 142 to the housing 128. The actuator 142 can comprise any desired type of actuator including, for example, a manual actuator and/or an automated actuator such as, for example, an electromechanical actuator including a solenoid-based actuator. In some embodiments, the actuator can comprise one or several buttons 144, and specifically, as depicted in FIG. 1, the actuator 142 can comprise a first button 144-A and a second button 144-B. Alternatively, and as depicted in FIG. 5, the actuator 142 can comprise a single button 144. In such an embodiment, the filament 150 can be coupled to the single button 144 and to a portion of the housing 128 such as, for example, to grip portion 500 of the housing 128 such that the movement of the single button 144 causes the sealing and/or opening of the elongate member 132 and of the valve 104.

The actuator 142 can be biased towards a configuration such as, for example, biased towards the first configuration or biased towards the second configuration. As depicted in FIG. 2, which shows the constricting mechanism 141 in the first configuration, the actuator 142 can be biased towards the first configuration wherein the elongate member 132 is collapsed and/or sealed by a bias feature 146. In this first configuration, the buttons 144 can be in a first position, also referred to herein as an undepressed position. This bias feature 146 can, as shown in FIG. 2, include a first spring 148-A configured to bias the first button 144-A towards the first position corresponding to the first configuration of the constricting mechanism 141, and a second spring 148-B configured to bias the second button 144-B towards a first position corresponding to the first configuration of the constricting mechanism 141. One or both of the first spring 148-A and the second spring 148-B can comprise a tension spring, compression spring, a torsion spring, a coil spring, or any other desired type of spring.

In some embodiments, one or both of the first spring 148-A and the second spring 148-B can generate sufficient force so as to allow actuation of the actuator 142 with a single hand and so as to collapse and seal the elongate member 132 when the constricting mechanism 141 is in the first configuration. In some embodiments, one or both of the first spring 148-A and the second spring 148-B can generate a force of: at least 0.1 pounds, at least 0.2 pounds, at least 0.3 pounds, at least 0.4 pounds, at least 0.5 pounds, at least 0.6 pounds, at least 0.7 pounds, at least 0.8 pounds, at least 0.9 pounds, at least 1 pound, at least 1.5 pounds, at least 2 pounds, at least 3 pounds, at least 5 pounds, and/or at least 10 pounds and in some embodiments one or both of the first spring 148-A and the second spring 148-B can generate a force approximately between: 0.1 and 10 pounds, 0.1 and 5 pounds, 0.1 and 1.5 pounds, 0.2 and 1 pounds, and/or 0.4 and 0.8 pounds.

The constricting mechanism 141 can include at least one filament 150 that extends at least partially around the elongate member 132. In some embodiments, the at least one filament 150 can circumferentially constrict the elongate member 132 to collapse and seal the elongate member 132 when the constricting mechanism 141 is in the first configuration. The filament can be made from a variety of materials including, for example, a polymer, a synthetic, and/or a metal. In some embodiments, the filament 150 can be nylon, stainless steel, nitinol, silicone, or the like. In some embodiments, the filament can comprise a single strand such as, for example, a monofilament, and in some embodiments, the filament can comprise a plurality of strands that can be, for example, twisted, woven, grouped, and/or fused to form the filament. In some embodiments, the filament 150 can comprise one or several threads, lines, cords, rope, ribbon, flat wire, sheet, or tape.

The filament 150 can be coupled to the actuator 142 such that the filament 150 selectively constricts, collapses, and/or seals the elongate member 132, and specifically the central lumen 138 of the elongate member 132 based on the movement and/or position of the actuator 142. In some embodiments, the filament 150 can be connected to one or both of the buttons 144-A, 144-B such that the filament 150 collapses, constricts, and/or seals the elongate member 132 and specifically the central lumen 138 of the elongate member 132 when the buttons 144-A, 144-B are in the first position, and the filament 150 can be connected to one or both of the buttons 144-A, 144-B such that the elongate member 132 and specifically the central lumen 138 of the elongate member 132 is open and uncollapsed when the buttons 144-A, 144-B are in the second position. In some embodiments in which the actuator 142 comprises a single button 144, as depicted in FIG. 5, the filament 150 can be connected to the button 144 and to the housing 128 such that the filament 150 is tightened when the button 144 moves to the first position.

In some embodiments, the at least one filament 150 can extend along an axis 152 that can be perpendicular to a central axis 154 of the elongate member 132 and/or of the apertures 124, 126. In some embodiments, the axis 152 of the at least one filament 150 can intersect and be perpendicular to the central axis 154 of the elongate member 132 and/or of the apertures 124, 126. In some embodiments, the actuator 142, and specifically the buttons 144-A, 144-B can move along this axis 152 when moved from the first position to the second position.

In FIG. 3, an embodiment of the valve 104 with the constricting mechanism 141 in the second configuration is shown. As specifically shown, both of the first and second buttons 144-A, 144-B are in the second position, depressed into the retention features 140 of the housing 128. In this second position, the filament 150 is loosened, thereby allowing the expansion of the elongate member 132 and the unsealing of the central lumen 138 of the elongate member 132.

As further seen in FIG. 3, the proximal cap 116 has a proximal end 300 and a distal end 302. The proximal cap 116 can include a funnel portion 301 of the proximal aperture 124, which funnel portion 301 can facilitate insertion of a tool into the proximal aperture 124. The distal end 302 of the proximal cap 116 can partially extend into the interior channel 130 of the housing 128. The proximal cap 116 can include a mating feature 304 that can mate with the proximal end 134 of the elongate member 132. In some embodiments, the proximal end 134 of the elongate member 132 can fit over the mating feature 304 of the proximal cap 116. The proximal end 134 of the elongate member 132 can be compressed between the mating feature 304 of the elongate member 132 and a portion of the interior channel 130 of the housing 128 into which the mating feature 304 is inserted to thereby secure the proximal end 134 of the elongate member 132 on the mating feature 304. In some embodiments, the proximal end 134 of the elongate member 132 can be further secured on the mating feature 304 by a proximal O-ring 306 that can be compressed between the housing 128 and the mating feature 304 of the proximal cap 116 to sealingly couple the elongate member 132 to the proximal cap 116.

The distal cap 120 has a proximal end 308 and a distal end 310. The distal cap can include a mating feature 312 located on the proximal end 308 of the distal cap 120, which mating feature 312 can mate with the distal end 136 of the elongate member 132. In some embodiments, the distal end 136 of the elongate member 132 can fit over the mating feature 312 of the distal cap 123. The distal end 136 of the elongate member 132 can be compressed between the mating feature 312 of the elongate member 132 and a portion of the interior channel 130 of the housing 128 into which the mating feature 312 is inserted to thereby secure the distal end 136 of the elongate member 132 on the mating feature 312. In some embodiments, the distal end 136 of the elongate member 132 can be further secured on the mating feature 312 by a distal O-ring 314 that can be compressed between the housing 128 and the mating feature 312 of the proximal cap 116 to sealingly couple the elongate member 132 to the distal cap 120.

The distal cap 120 can, in some embodiments, further include a side port barb 314 that can extend laterally away from the distal cap 120 and specifically away from the distal aperture 126 of the distal cap 120. The side port barb 314 can define a side port channel 316 that can extend through the side port barb 314 and fluidly connect to the distal aperture 126. In some embodiments, the side port barb 314 can include a securement feature 318 such as a barb that can secure coupling of a hose or tube to the side port barb 314.

In some embodiments, the side barb 314 can be used to apply a vacuum to the portions of the delivery device 100, and particularly to portions of the delivery device 100 that are distal of the axis 152 along which the elongate member 132 seals. This vacuum can be applied to aspirate a material through the delivery device 100, and specifically through the catheter 102 of the delivery device. This aspirated material can be a biological material including, for example, bodily fluids, multi-phase bodily materials that can include, for example, a fluidic portion and at least one solid portion, or the like.

In some embodiments, due to the narrowing shape of the elongate member 132 when the constricting mechanism 141 is in the first configuration, a vacuum applied to the portions of the delivery device 100 distal to the axis 152 draws the elongate member 132 towards the first configuration and can, in some embodiments, increase the strength, robustness, and/or strength of the seal of the valve 104. This attribute of the valve 104 can provide benefits over other valve designs in which a vacuum can compromise the seal of the valve, and thus the ability to draw a vacuum and aspirate can be limited.

In some embodiments, the valve 104 can further include a reinforcement structure 320 that can extend along all or portions of the elongate member 132. The reinforcement structure 320 can facilitate the uniform collapse of the elongate member 132, can prevent the at least one filament 150 from cutting through and/or tearing the elongate member 132, and can assist in guiding one or several tools through the elongate member 132. The reinforcement structure 320 can be tubular, can extend along and around the elongate member 132, and can be positioned so as to be between the elongate member 132 and the at least one filament 150.

The reinforcement structure 320 can include a proximal end 322 and a distal end 324. In some embodiments, the reinforcement structure 320 extends along and around the elongate member 132, and is positioned such that the proximal end 322 of the reinforcement structure 320 is proximate to the first end 134 of the elongate member 132 and the distal end 324 of the reinforcement structure 320 is proximate to the second end 136 of the elongate member 132.

The reinforcement structure 320 can be coupled to the elongate member 132. In some embodiments, the reinforcement structure 320 is coupled to the elongate member 132 along the length of the reinforcement structure 320, and in some embodiments, the reinforcement structure 320 is coupled to the elongate member 132 and distinct positions along the length of the elongate member 132 and/or the reinforcement structure 320. In one embodiment, for example, the reinforcement structure 320 can be coupled to the elongate member 132 at one or both of the proximal end 322 of the reinforcement structure 320 and the distal end 324 of the reinforcement structure 320 and/or at one or both of the first end 134 and the second end 136 of the elongate member 132. In some embodiments, the reinforcement structure 320 can be coupled to the elongate member 132 via one or several other components of the valve 104. In some embodiments, the reinforcement structure 320 can be coupled to the elongate member 132 via the compression of the reinforcement structure 320 and the elongate member 132 between the housing 128 and one or both of the proximal 116 and the distal 120.

In some embodiments, the reinforcement structure 320 can be adhered to the elongate member 132 via, for example, an adhesive such as silicone adhesive. In some embodiments, the adhesive can be circumferentially applied to the reinforcement structure 320 and/or the elongate member 132 in an adhesive ring that can, for example, a have a length approximately between: 0.010 inches and 0.5 inches; 0.02 and 0.4 inches; 0.050 inches and 0.0250 inches, or any other or intermediate range.

In one embodiment, each of the proximal end 322 and the distal end 324 of the reinforcement structure 320 can be adhered via an adhesive to the elongate member 132. In such an embodiment, the reinforcement structure 320 may be uncoupled to the elongate member 132 at positions other than the coupling at one or both of the proximal end 322 and the distal end 324 of the reinforcement structure 320, and thus the reinforcement structure 320 is uncoupled to the elongate member 132 at a position between the first end 134 and the second end 136 of the elongate member 134 and/or between the proximal end 322 and the distal end 324 of the reinforcement structure 320.

The lack of coupling of the reinforcement structure 320 to the elongate member 132 can facilitate and improve the collapse of the elongate member 132 around a tool 400, also referred to herein as instrument 400 or device 400, inserted through the valve 104 as shown in FIG. 4. The tool 400 can be any device inserted through the valve 104 including, for example, one or several additional catheters, lines, wires, grippers, punches, cutters, or the like. As seen in FIG. 4, the tool 400 is inserted through the valve 104 and specifically through the elongate member 132 of the valve. As shown, the constricting mechanism 141 is in the first configuration and the elongate member 132 and the central lumen 138 of the elongate member 132 is collapsed around the tool 400, and specifically around a shaft 402 of the tool 400 to thereby seal the valve 104 around the tool 400 and specifically around the shaft 402 of the tool 400. The constricting mechanism 141 can seal around tools 400 that fit through the elongate member 132, regardless of the size of the tool 400. Thus, the valve can be used with a wide variety of tools.

The reinforcement structure 320 can comprise a variety of designs, shapes, sizes, and materials. In some embodiments, the reinforcement structure 320 can be sized and shaped so as to receive elongate member 132 and to be positioned between the elongate member 132 and the at least one filament 150. In some embodiments, the reinforcement structure 320 can be made from a material sufficiently strong to prevent the cutting of the at least one filament 150 through the elongate member 132.

In some embodiments, the reinforcement structure can comprise a coil or a mesh sheath. The mesh sheath can, in some embodiments, comprise a braided mesh. The braided mesh can be made from any desired number of wires in any desired configuration. In some embodiments, the braided mesh can comprise a 4 wire braided mesh, an 8 wire braided mesh, a 12 wire braided mesh, a 16 wire braided mesh, a 20 wire braided mesh, a 24 wire braided mesh, a 32 wire braided mesh, a 48 wire braided mesh, a 64 wire braided mesh, a 72 wire braided mesh, an 80 wire braided mesh, a 96 wire braided mesh, or any other or intermediate braided mesh. In some embodiments, the braided mesh can comprise: a 1×1 configuration. In some embodiments, the wire in the braided mesh can be any desired material including, for example, a metal wire such as a nitinol wire or a stainless steel wire, a polymer wire, or a natural wire. In one embodiment, the braided mesh can comprise a 48 wire mesh in a 1×1 configuration made with a nitinol wire having a diameter of 0.003 inches.

With reference now to FIGS. 6 through 9, different embodiments and/or configurations of the filament 150 are shown. The filament 150 can comprise a single filament 150 having a first end 600 and a second end 602 as shown in FIG. 6. The filament 150, and specifically which first and second ends 600, 602 can be coupled to the actuator 142 to move the filament 150 between the first and second configurations or positions and/or from the first configuration or position to the second configuration or position. In some embodiments, both of the first end 600 and the second end 602 can be coupled to a single button 144, in some embodiments, each of the first end 600 and the second end 602 can be coupled to different buttons 144, and in some embodiments, one of the first end 600 and the second end 602 can be coupled to a button 144 and the other of the first end 600 and the second end 602 can be coupled to the housing 128 or other portion of the valve 104.

In some embodiments, the filament 150 can comprise multiple filaments, and specifically, as shown in FIGS. 7 through 9, the filament 150 can comprise a first filament 150-A and a second filament 150-B. In embodiments in which the filament 150 comprises multiple filaments, each of the multiple filaments can have a first end 700 and a second end 702. The first and second filaments 150-A, 150-B can be coupled to the actuator 142. In such embodiments, the first and second ends 700, 702 can be coupled to the actuator 142 to move the filaments 150-A, 150-B between the first and second configurations and/or from the first configuration to the second configuration. In some embodiments, both of the first end 700 and the second end 702 of one or more of the multiple filaments 150 can be coupled to a single button 144, in some embodiments, each of the first end 700 and the second end 702 of one or more of the multiple filaments 150 can be coupled to different buttons 144, and in some embodiments, one of the first end 700 and the second end 702 of one or more of the multiple filaments 150 can be coupled to one button 144 and the other of the first end 700 and the second end 702 of those one or more filaments 150 can be coupled to the housing 128 or other portion of the valve 104.

The filament 150 can be arranged in a variety of configurations. In some embodiments, the filament 150 can be configured to form a single loop 604 that can extend around the elongate member 132 and/or through which the elongate member 132 can be received as shown in FIG. 6, and in some embodiments, the filament 150 can be configured to form multiple loops, and specifically a first loop 704 and a second loop 706 as shown in FIG. 7. The first and second loops 704, 706 can each receive the elongate member 132. In some embodiments, a diameter or size of the loop 604, or of the loops 704, 706 can decrease when the constricting mechanism 141 is moved from the second configuration to the first configuration.

In some embodiments, the filament 150 can be configured to form a bight 800, which bight 800 can be a single bight or multiple bights. As used herein, a “bight” refers to a U-shaped section between the two ends of the filament 150. As depicted in FIGS. 8 and 9, the bight 800 can comprise multiple bights, and specifically a first bight 800-A and a second bight 800-B. In some embodiments, the first bight 800-A can extend through the second bight 800-B such that the first and second bights 800-A, 800-B interlock, whereas in other embodiments, the first and second bights 800-A, 800-B can be non-interlocking. Similarly, in embodiments containing the filament 150 having multiple loops, one or several of the multiple loops can be interlocking.

In some embodiments, the bight 800, and specifically one or both of the first bight 800-A and the second bight 800-B can be formed around a portion of the elongate member 132 and/or can extend around a portion of the elongate member 132. Each bight 800 can define a partially enclosed receiving area 808 wherein the elongate member 132 can be received. Thus, the first bight 800-A can define a first receiving area 808-A and the second bight 800-B can define a second receiving area 808-B.

As seen in FIGS. 8 and 9, multiple bights, and specifically the first and the second bights 800-A, 800-B can be positioned and oriented such that the first bight 800-A has a first orientation or first direction as indicated by arrow 810, and the second bight has a second orientation or second direction as indicated by the arrow 812. In some embodiments, the first orientation is different from the second orientation such that the first and second receiving areas 808-A, 808-B overlap and define an encircled area 814, also referred to herein as a constricting area 814. The elongate member 132 can be received within the encircled area 814. In embodiments in which bights 800-A, 800-B overlap to define the encircled area 814, the movement of the constricting mechanism 141 to the first configuration can result in and/or include the first bight 800-A moving in the direction indicated by the arrow 810 and/or the second bight 800-B moving in the direction indicated by the arrow 812, which movement of the bights 800-A, 800-B decreases the size of the encircled area 814 and constricts, collapses, and/or seals the elongate member 132 extending through the encircled area 814.

The filament(s) 150 forming the bights 800 can each apply an arcuate line or narrow longitudinal zone of pressure to the elongate member 132. If the filament(s) are circular in cross-section, the zone of pressure can be very small, and can, in some embodiments, be less than the diameter or thickness of the filament. In some embodiments, the filaments have a diameter or width less than about 2.5 mm, less than about 2 mm, less than about 1.5 mm, less than about 1.25 mm, less than about 1 mm, less than about 0.75 mm, less than about 0.5 mm, and/or less than about 0.25 mm. In some embodiments, the filaments can have a diameter or width of between about 0.01 mm and 2.5 mm, between about 0.05 mm and 2 mm, between about 0.1 mm and 1 mm, and/or between about 0.125 mm and 0.70 mm. In some embodiments, the arcuate line or zone of pressure may form two opposing arcs and in other embodiments, the arcuate line of pressure may be a singular substantially circular line or zone that encircles the elongate member at least once. The longitudinal length of the of the line or zone of pressure may be very short compared to other valves known in the art. In some embodiments, the longitudinal length of the zone of pressure applied to the elongate member 132 by the filament(s) 150 may be less than about 2.0 mm and in some embodiments less than about 0.5 mm. In some embodiments, the filament(s) 150 can have any desired cross-sectional shape including, for example, a circular cross-section, a rectangular cross-section, an oval cross-section, a square cross-section, a polygonal cross-section, a triangular cross-section, or any other desired shape of cross-section.

With reference now to FIG. 10, a flowchart illustrating one embodiment of a process 1000 for sealing a valve 104 and/or catheter 102 accessing a body of a patient is shown. The process 1000 can be performed using the valve 104 and/or the delivery system 100. The process 1000 begins at block 1002, wherein the delivery device 100, and specifically the catheter 102 of the delivery device 100 is inserted into the body of the patient. In some embodiments, this can include inserting the catheter 102 into a portion of the circulator system of the patient such as, for example, a blood vessel including an artery or a venous vessel. In some embodiments, the delivery device 100 can be inserted into the body of the patient directly through an aperture or incision in the patient, and in some embodiments, the delivery device 100 can be inserted into the body of the patient via another catheter or device. In some embodiments, the constricting mechanism 141 can be in the first configuration while the delivery device 100 and/or the catheter 102 is inserted into the patient's body.

After the delivery device 100 is inserted into the body of the patient, the process 1000 proceeds to block 1004, wherein the constricting mechanism 141 is moved from the first configuration to the second configuration. As described above, the central lumen 138 of the elongate member 132 is unsealed when the constricting mechanism 141 is in the second configuration. In some embodiments, the moving of the constricting mechanism 141 from the first configuration to the second configuration can include the manipulation of the actuator 142 and/or the control of the actuator 142, and specifically the depressing of the one or several buttons 144 to move the filament 150 from the first position to the second position to allow the expansion and opening of the central lumen 138 of the elongate member 132.

After the constricting mechanism 141 is moved from the first configuration to the second configuration, the process 1000 proceeds to block 1006, wherein the tool 400, and specifically the shaft 402 of the tool 400 is advanced through the delivery device 100 and specifically through the valve 104 until a first end of the tool reaches a desired position within the body of the patient. In some embodiments, a portion of the shaft 402 can be positioned within the central lumen 138 of the elongate member 132 after the advancing of the tool 400 through the delivery device 100. In some embodiments, after the tool 400 is advanced through the delivery device 100, the desired procedure can be performed with the tool.

After the tool 400 is advanced through the delivery device 100, or while the tool 400 is being advanced through the delivery device 100, the process 1000 proceeds to block 1008, wherein the constricting mechanism 141 is returned to the first configuration. In some embodiments, the returning of the constricting mechanism 141 to the first configuration can include the release of the one or several buttons 144 and/or the control of the actuator 142 to reconfigure the constricting mechanism 141 to the first configuration. In some embodiments, the return of the constricting mechanism 141 to the first configuration can result in the collapse and/or sealing of the elongate member 132 and specifically the central lumen 138 of the elongate member 132 around the tool 400 and specifically around the shaft 402 of the tool 400. The return of the constricting mechanism 141 to the first configuration, or the movement of the constricting mechanism 141 to the first configuration can include the decreasing of the size and/or diameter of one or several loops formed by the filament 150 and/or the movement of one or several bights 800 such as, for example, the movement of the first bight 800-A in the first direction indicated by arrow 810 and the movement of the second bight 800-B in the second direction indicated by arrow 812 to reduce the size of the constricting area 814. In some embodiments, after the constricting mechanism is returned to the first configuration, the desired procedure can be performed with the tool.

After the constricting mechanism is returned to the first configuration, the process 1000 proceeds to block 1010, wherein the tool 400, and specifically the shaft 402 of the tool 400 is retracted from the delivery device 100, and more specifically from the valve 104. In some embodiments, the valve 104 can remain sealed during the retracing of the tool 400 and/or the shaft 402 of the tool. In some embodiments, the valve 104 remains sealed during the retracting of the tool 400 and/or the retracting of the shaft 402 of the tool 400 as the constricting mechanism 141 can remain in the first configuration during the retracing of the tool 400 and/or the shaft 402 of the tool 400.

In some embodiments, the constricting mechanism 141 can be moved to the second configuration to allow the retraction of the tool 400 and/or the shaft 402 of the tool 400 from the valve 104, and the constricting mechanism 141 can be returned to the first configuration when the tool 400 and/or the shaft 402 of the tool 400 is removed from the valve 104. In some embodiments, the retraction of the tool 400 and/or shaft 402 of the tool 400 from the valve 104 can be performed with the constricting mechanism 141 left in the first configuration. In some embodiments, the constricting mechanism 141 can be moved to the second configuration, and then returned to the first configuration via the manipulation and/or control of the actuator 142, which manipulation and/or control of the actuator 142 can include the depressing of the one or several buttons 144 to move the constricting mechanism 141 to the second configuration, and the release of the one or several buttons 144 to return the constricting mechanism 141 to the first configuration. In some embodiments, if the procedure is complete, the delivery device 100 can then be removed from the body of the patient, and any incision created for the procedure can be closed.

With reference now to FIG. 11, a side view of one embodiment of a thrombectomy system 1100 including the delivery device 100 and a thrombus extraction device 1102 is shown. In some embodiments, the thrombectomy system 1100 can be used to access a blood vessel 1104 to treat and/or extract a thrombus 1106 from the blood vessel 1104. The thrombus extraction device 1102 can include a self-expanding coring element 206 and expandable cylindrical portion 208. In some embodiments, and as shown in FIG. 11, the thrombus extraction device 1102 can be the tool 400 that can extend through the valve 104, and in some embodiments, the valve 104 can be a part of the thrombus extraction device 1102. Further details of thrombectomy systems, thrombus extraction devices, and methods of using the same are disclosed in: U.S. application Ser. No. 15/268,296, filed Sep. 16, 2016, and entitled “INTRAVASCULAR TREATMENT OF VASCULAR OCCLUSION AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS”; U.S. application Ser. No. 15/498,320, filed Apr. 26, 2017, and entitled “DEVICES AND METHODS FOR TREATING VASCULAR OCCLUSION”; and U.S. application Ser. No. 15/466,740, filed on Mar. 22, 2017, and entitled “DEVICE AND METHOD FOR TREATING VASCULAR OCCLUSION”, the entirety of each of which is hereby incorporated by reference herein.

With reference now to FIG. 12, a side-section view of another embodiment of the hemostasis valve 104 having two piece caps 116, 120 is shown. The valve 104 can include a housing 128 defining an interior channel 130 through which the tubular member 132 can extend. The valve 104 can include the proximal cap 116 and the distal cap 120. In some embodiments, the proximal cap 116 can comprise a two piece cap and can include a proximal exterior member 1200 and a proximal channel member 1202. In some embodiments, the distal cap 120 can comprise a two-piece cap and can include a distal exterior member 1204 and a distal channel member 1206. In some embodiments, this coupling between the proximal exterior member 1200 and the proximal channel member 1202 and/or the coupling between the distal exterior member 1204 and the distal channel member 1206 can be a sealed coupling so as to prevent the leakage of material including fluid or gas between the respective ones of the proximal exterior member 1200 and the proximal channel member 1202 and/or the distal exterior member 1204 and the distal channel member 1206. In some embodiments, this sealing coupling can be achieved and/or maintained via a seal such as an O-ring 1208 that can be positioned between the proximal exterior member 1200 and the proximal channel member 1202 and/or between the distal exterior member 1204 and the distal channel member 1206.

In some embodiments, the proximal exterior member 1200 can be coupled, and in some embodiments, rotatingly coupled to the proximal channel member 1202 in a manner to allow the rotation of the proximal exterior member 1200 without rotating the proximal channel member 1202. Similarly, in some embodiments, the distal exterior member 1204 can be rotatingly coupled to the distal channel member 1206 in a manner to allow the rotation of the distal exterior member 1204 without the rotating of the distal channel member 1206. In some such embodiments, the channel members 1202, 1206 can be non-rotatable with respect to the housing 128 and/or the tubular member 132, and one or both of the exterior members 1200, 1204 can be rotatable with respect to the housing 128 and/or the tubular member 132. In such an embodiment, the maintaining of the rotational position of the channel members 1202, 1206 with respect to the housing 128 and/or the tubular member 132 can prevent the twisting of the tubular member 132 which can result in the sealing of the tubular member 132 regardless of the configuration of the constructing mechanism 141.

The exterior members 1200, 1204 can comprise a variety of shapes and sizes and can include a variety of features. In some embodiments, one or both of the exterior members 1200, 1204 can be coupled to, for example, a shaft similar to the shaft 106 shown in FIG. 1. In some embodiments, for example, the distal exterior member 1204 can be coupled to a shaft 106, including, for example, can be non-detachably coupled to the shaft 106. In some embodiments, one or both of the exterior members can include one or several features configured to facilitate coupling with the valve 104. These one or several features can include, for example, one or several male or female: connectors; couplers; attachment mechanisms; or the like. In some embodiments, these one or several features can facilitate use of the valve with other existing components, instruments, tools, or the like. In some embodiments, for example, one or both of the exterior members 1200, 1204 can comprise either a male or female luer fitting, and specifically as shown in FIG. 12, the distal exterior member 1204 can comprise a male luer fitting 1210.

Several aspects of the present technology are set forth in the following examples.

1. A hemostatic valve for sealing a medical device, the hemostatic valve comprising:

- an elongate member having a first end, a second end, and a central lumen extending therebetween, wherein the elongate member is pliable;
- a reinforcement structure extending along at least a portion of the elongate member, wherein the reinforcement structure is coupled to the elongate member; and
- an active tensioning mechanism coupled to the elongate member, wherein the tensioning mechanism is moveable between a first configuration wherein the central lumen is constricted and sealed and a second configuration wherein the central lumen is open.

2. The hemostatic valve of example 1, wherein the elongate member comprises a compliant polymer tube.

3. The hemostatic valve of example 1 or 2, wherein the tensioning mechanism comprises at least one filament extending at least partially around the elongate member.

4. The hemostatic valve of example 3, wherein the reinforcement structure is positioned between the at least one filament and the elongate member.

5. The hemostatic valve of example 4, wherein the reinforcement structure comprises a braided mesh.

6. The hemostatic valve of example 4 or 5, wherein the reinforcement structure is coupled to the elongate member at a position proximate to the first end of the elongate member and at a position proximate to the second end of the elongate member.

7. The hemostatic valve of example 6, wherein the reinforcement structure is not coupled to the elongate member at a position between the first end of the elongate member and the second end of the elongate member.

8. The hemostatic valve of any one of examples 3-7, wherein the tensioning mechanism comprises an actuator coupled to the at least one filament, wherein the actuator is moveable to control movement of the at least one filament from a first position wherein the central lumen is constricted and sealed to a second position wherein the central lumen is open, wherein the at least one filament is in the first position when the tensioning mechanism is in the first configuration.

9. The hemostatic valve of example 8, wherein the actuator is biased towards the first position.

10. The hemostatic valve of example 8 or 9, wherein the actuator is biased toward the second position.

11. The hemostatic valve of any one of examples 8-10, wherein the actuator comprises a manual actuator.

12. The hemostatic valve of any one of examples 8-11, wherein the at least one filament forms a loop around the elongate member.

13. The hemostatic valve of any one of examples 8-12, wherein the at least one filament forms a bight around a portion of the elongate member.

14. The hemostatic valve of any one of examples 8-13, wherein the at least one filament comprises a first filament and a second filament, wherein each of the first filament and the second filament are coupled to the actuator, and wherein the first filament and the second filament are moveable from the first position to the second position.

15. The hemostatic valve of example 14, wherein each of the first filament and the second filament form a loop around the elongate member.

16. The hemostatic valve of example 14 or 15, wherein the first filament forms a first bight around a first portion of the elongate member, and wherein the second filament forms a second bight around a second portion of the elongate member.

17. The hemostatic valve of example 16, wherein the first bight extends through the second bight.

18. The hemostatic valve of any one of examples 1-17, further comprising a shell defining a first aperture and a second aperture, wherein the elongate member extends from the first aperture to the second aperture and fluidly couples the first aperture and the second aperture.

19. The hemostatic valve of any one of examples 1-18, wherein the tensioning mechanism is self-adjustable to seal around tools of different sizes extending through the hemostatic valve.

20. The hemostatic valve of any one of examples 1-19, wherein the central lumen comprises a single lumen.

21. The hemostatic valve of any one of examples 1-20, wherein the central lumen comprises a plurality of lumens.

22. A delivery system for intravascular access of a blood vessel within a patient's body, the delivery system comprising:

a catheter having a first end, a second end, and a catheter lumen extending therebetween;

a hemostatic valve coupled to the first end of the catheter, the hemostatic valve comprising:

- a tubular member having a first end, a second end, and a central lumen extending therebetween, wherein the central lumen of the tubular member is fluidly coupled with the catheter lumen; and
- an active tensioning mechanism coupled to the tubular member, the tensioning mechanism moveable between a first configuration wherein the tensioning mechanism constricts on the central lumen and the central lumen is sealed and a second configuration wherein the central lumen is open.

23. The delivery system of example 22, wherein the hemostatic valve further comprises a reinforcement structure extending along at least a portion of the tubular member.

24. The delivery system of example 22 or 23, wherein the reinforcement structure is located between the tensioning mechanism and the tubular member.

25. The delivery system of example 24, wherein the reinforcement structure comprises a braided mesh.

26. The delivery system of example 24 or 25, wherein the reinforcement structure is coupled to the tubular member at a position proximate to the first end of the tubular member and at a position proximate to the second end of the tubular member.

27. The delivery system of example 26, wherein the reinforcement structure is adhered to the tubular member at the first end of the tubular member and at the second end of the tubular member.

28. The delivery system of example 27, wherein the reinforcement structure is uncoupled to the tubular member between the first end of the tubular member and the second end of the tubular member.

29. The delivery system of any one of examples 22-28, wherein the tensioning mechanism comprises at least one filament extending at least partially around the tubular member.

30. The delivery system of example 29, wherein the tensioning mechanism comprises an actuator coupled to the at least one filament, wherein moving the tensioning mechanism from the first configuration to the second configuration comprises moving the actuator and the thereto coupled at least one filament from a first position to a second position, wherein the filament constricts and seals the central lumen of the tubular member when the filament is in the first position.

31. The delivery system of example 30, wherein the actuator comprises a manual actuator.

32. The delivery system of example 31, wherein the actuator comprises a pair of opposing and depressable buttons, wherein the buttons are biased towards an undepressed position.

33. The delivery system of example 31 or 32, wherein the central lumen is sealed when the buttons are in the undepressed position.

34. The delivery system of any one of examples 30-33, wherein the filament comprises a monofilament.

35. The delivery system of any one of examples 30-34, wherein the filament comprises at least one of: a polymer filament; or a metallic filament.

36. The delivery system of any one of examples 22-35, wherein the catheter comprises a thrombus extraction device.

37. A method of sealing a delivery device accessing a blood vessel of a patient, the method comprising:

- inserting the delivery device comprising a catheter and a hemostatic valve into the blood vessel of the patient, the catheter having a first end, a second end, and a catheter lumen extending therethrough, and the hemostatic valve coupled to the first end and having a tubular member defining a central lumen fluidly coupled with the catheter lumen and a tensioning mechanism coupled with the tubular member, wherein the tensioning mechanism collapses and seals the central lumen in a first configuration and thereby seals access to the blood vessel;
- moving the tensioning mechanism of the hemostatic valve to a second configuration, wherein the central lumen is open and access to the blood vessel is unsealed when the tensioning mechanism is in the second configuration;
- advancing a shaft of a tool through the delivery device until a first end of the tool reaches a desired position within the blood vessel of the patient and a portion of the shaft is positioned within the central lumen of the tubular member; and
- returning the tensioning mechanism of the hemostatic valve to the first configuration such that the tubular member collapses on the shaft of the tool and seals around the shaft of the tool.

38. The method of example 37, further comprising retracting the shaft of the tool from the delivery device.

39. The method of example 38, wherein the tensioning mechanism is maintained in the first configuration during and after the retracting of the shaft of the tool from the delivery device.

40. The method of example 38 or 39, wherein the tensioning mechanism is moved to the second configuration during the retracting of the shaft of the tool from the delivery device, and wherein the tensioning mechanism is returned to the first configuration after the shaft of the tool is retracted from the delivery device.

41. The method of any one of examples 37-40, wherein the tensioning mechanism comprises at least one filament extending at least partially around the tubular member, wherein the at least one filament collapses the tubular member when the tensioning mechanism is in the first configuration.

42. The method of example 41, wherein the at least one filament circumferentially constricts the tubular member to collapse the tubular member when the tensioning mechanism is in the first configuration.

43. The method of example 41 or 42, wherein the hemostatic valve comprises a reinforcement structure located between the at least one filament and the tubular member.

44. The method of any one of examples 41-43, wherein the at least one filament forms a loop around the elongate member, and wherein moving the tensioning mechanism from the second configuration to the first configuration reduces a size of the loop to thereby constrict the tubular member within the loop.

45. The method of any one of examples 41-44, wherein the filament forms at least one bight around a portion of the elongate member.

46. The method of example 45, wherein the filament comprises a first filament and a second filament, and wherein the at least one bight comprises a first bight oriented in a first direction and formed by the first filament and a second bight oriented in a second direction and formed by the second filament, wherein the first and second bights overlap to encircle a portion of the tubular member within an constricting area.

47. The method of example 46, wherein moving the tensioning mechanism from the second configuration to the first configuration comprises moving the first bight in the first direction and the second bight in the direction to reduce the size of the constricting area and collapse and seal the central lumen of the tubular member.

48. The method of any one of examples 37-47, wherein the tensioning mechanism comprises an actuator, and wherein moving the tensioning mechanism to the second configuration comprises manipulating the actuator.

49. The method of any one of examples 37-48, further comprising applying a vacuum to the delivery device to aspirate material through the catheter, wherein the central lumen remains sealed during the aspiration.

50. The method of any one of examples 37-49, wherein the tool comprises a thrombus extraction device.

51. A hemostatic valve for sealing a medical device, the hemostatic valve comprising:

- an elongate member having a first end, a second end, and a central lumen comprising a plurality of lumens extending therebetween, wherein the elongate member is pliable; and
- an active tensioning mechanism coupled to the elongate member, wherein the tensioning mechanism is moveable between a first configuration wherein the central lumen is constricted and sealed and a second configuration wherein the central lumen is open.

Other variations are within the spirit of the present invention. Thus, while the invention is susceptible to various modifications and alternative constructions, certain illustrated embodiments thereof are shown in the drawings and have been described above in detail. It should be understood, however, that there is no intention to limit the invention to the specific form or forms disclosed, but on the contrary, the intention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention, as defined in the appended claims.

In the previous description, various embodiments of the present invention are described. For purposes of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the embodiments. However, it will also be apparent to one skilled in the art that the present invention may be practiced without the specific details. Furthermore, well-known features may be omitted or simplified in order not to obscure the embodiment being described.

The use of the terms “a” and “an” and “the” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. The term “connected” is to be construed as partly or wholly contained within, attached to, or joined together, even if there is something intervening. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate embodiments of the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.

Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.

All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.

Claims

1. An aspiration catheter, comprising: an elongate, flexible tubular body, having a proximal end, a distal end and a central lumen;a hemostasis valve on the proximal end of the catheter, the hemostasis valve comprising (a) a collapsible tubular sidewall defining a valve lumen in communication with the central lumen; and(b) a constricting mechanism having at least a first actuator, a first filament formed into a loop around the collapsible tubular sidewall, the filament having at least a first end portion extending away from the loop and connected to the first actuator, and a first spring configured to move the first actuator in a direction that pulls the first end portion such that a diameter of the valve lumen decreases in response to reducing a diameter of the loop.
2. The aspiration catheter of claim 1 wherein: the collapsible tubular sidewall comprises a tubular member defining the valve lumen configured to slidably receive the elongate, flexible tubular body;the constricting mechanism further comprises a second actuator and a second spring coupled to the second actuator; andthe filament further comprises a second end portion extending away from the loop in a different direction than the first end portion and connected to the second actuator, and wherein the first actuator and the second actuator are moveable between (a) a first position wherein the filament circumferentially constricts the valve lumen to create a seal about the elongate, flexible tubular body and (b) a second position wherein the filament is moved to open the valve lumen at least partially.
3. The aspiration catheter of claim 2 wherein the tubular member is pliable.
4. The aspiration catheter of claim 2 wherein the first actuator comprises a first button and the second actuator comprises a second button, wherein the first button and the second button are undepressed in the first position, and wherein the first button and the second button are depressed in the second position.
5. The aspiration catheter of claim 2 wherein, when the first actuator and the second actuator are in the first position, the valve lumen of the tubular member is configured to remain constricted and sealed when a pressure differential exists between (a) a first volume outside the valve lumen and adjacent to a first end of the tubular member and (b) a second volume outside the central lumen and adjacent to a second end of the tubular member.
6. The aspiration catheter of claim 2 wherein, when the first actuator and the second actuator are in the first position, the valve lumen of the tubular member is configured to remain constricted and sealed when vacuum pressure is applied to a volume outside the valve lumen and adjacent to either a first end or a second end of the tubular member.
7. The aspiration catheter of claim 2 wherein the valve lumen of the tubular member extends a long a first longitudinal axis, wherein the first actuator and the second actuator are movable between the first and second positions along a second longitudinal axis, and wherein the first longitudinal axis is orthogonal to the second longitudinal axis.
8. The aspiration catheter of claim 2 wherein the first spring comprises a first compression spring coupled to the first member and the second spring comprises a second compression spring coupled to the second member.
9. The aspiration catheter of claim 2 wherein, in the first position, the first actuator and the second actuator pull the filament to circumferentially constrict the collapsible tubular member such that the valve lumen is constricted and sealed.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/705,189, filed on Mar. 25, 2022, entitled “HEMOSTASIS VALVES AND METHODS OF USE,” which is a continuation of U.S. patent application Ser. No. 17/226,318, filed on Apr. 9, 2021, entitled “HEMOSTASIS VALVES AND METHODS OF USE,” which is a continuation of U.S. patent application Ser. No. 16/117,519, filed on Aug. 30, 2018, now issued as U.S. Pat. No. 11,000,682, and entitled “HEMOSTASIS VALVES AND METHODS OF USE,” which claims the benefit of U.S. Provisional Patent Application No. 62/554,931, filed on Sep. 6, 2017, and entitled “HEMOSTASIS VALVES AND METHODS OF USE,” each of which is herein incorporated by reference in its entirety.

US Referenced Citations (719)

Number	Name	Date	Kind
2846179	Monckton	Aug 1958	A
2955592	Maclean	Oct 1960	A
3088363	Sparks	May 1963	A
3197173	Taubenheim	Jul 1965	A
3435826	Fogarty	Apr 1969	A
3515137	Santomieri	Jun 1970	A
3675657	Gauthier	Jul 1972	A
3892161	Sokol	Jul 1975	A
3923065	Nozick et al.	Dec 1975	A
4030503	Clark, III	Jun 1977	A
4034642	Iannucci et al.	Jul 1977	A
4222380	Terayama	Sep 1980	A
4243040	Beecher	Jan 1981	A
4287808	Leonard et al.	Sep 1981	A
4324262	Hall	Apr 1982	A
4393872	Reznik et al.	Jul 1983	A
4469100	Hardwick	Sep 1984	A
4523738	Raftis et al.	Jun 1985	A
4551862	Haber	Nov 1985	A
4604094	Shook	Aug 1986	A
4611594	Grayhack et al.	Sep 1986	A
4643184	Mobin-Uddin	Feb 1987	A
4646736	Auth et al.	Mar 1987	A
4650466	Luther	Mar 1987	A
4776337	Palmaz	Oct 1988	A
4790812	Hawkins, Jr. et al.	Dec 1988	A
4863440	Chin et al.	Sep 1989	A
4870953	DonMichael et al.	Oct 1989	A
4883458	Shiber	Nov 1989	A
4886062	Wiktor	Dec 1989	A
4890611	Monfort et al.	Jan 1990	A
4898575	Fischell et al.	Feb 1990	A
4946440	Hall	Aug 1990	A
4960259	Sunnanvader et al.	Oct 1990	A
4978341	Niederhauser	Dec 1990	A
5059178	Ya	Oct 1991	A
5100423	Fearnot	Mar 1992	A
5127626	Hilal et al.	Jul 1992	A
5129910	Phan et al.	Jul 1992	A
5135484	Wright	Aug 1992	A
5154724	Andrews	Oct 1992	A
5158533	Strauss et al.	Oct 1992	A
5158564	Schnepp-Pesch et al.	Oct 1992	A
5192274	Bierman	Mar 1993	A
5192286	Phan et al.	Mar 1993	A
5192290	Hilal	Mar 1993	A
5197485	Grooters	Mar 1993	A
5329923	Lundquist	Jul 1994	A
5360417	Gravener et al.	Nov 1994	A
5364345	Lowery et al.	Nov 1994	A
5376101	Green et al.	Dec 1994	A
5383887	Nadal	Jan 1995	A
5389100	Bacich et al.	Feb 1995	A
5419774	Willard et al.	May 1995	A
5421824	Clement et al.	Jun 1995	A
5443443	Shiber	Aug 1995	A
5456667	Ham et al.	Oct 1995	A
5476450	Ruggio	Dec 1995	A
5490859	Mische et al.	Feb 1996	A
5496365	Sgro	Mar 1996	A
5527326	Hermann et al.	Jun 1996	A
5549626	Miller et al.	Aug 1996	A
5591137	Stevens	Jan 1997	A
5653684	Laptewicz et al.	Aug 1997	A
5662703	Yurek et al.	Sep 1997	A
5746758	Nordgren et al.	May 1998	A
5749858	Cramer	May 1998	A
5769816	Barbut et al.	Jun 1998	A
5782817	Franzel et al.	Jul 1998	A
5800457	Gelbfish	Sep 1998	A
5827229	Auth et al.	Oct 1998	A
5846251	Hart	Dec 1998	A
5860938	Lafontaine et al.	Jan 1999	A
5873866	Kondo et al.	Feb 1999	A
5873882	Straub et al.	Feb 1999	A
5876414	Straub	Mar 1999	A
5895406	Gray et al.	Apr 1999	A
5908435	Samuels	Jun 1999	A
5911710	Barry et al.	Jun 1999	A
5911733	Parodi	Jun 1999	A
5911754	Kanesaka et al.	Jun 1999	A
5941869	Patterson et al.	Aug 1999	A
5947985	Imran	Sep 1999	A
5954737	Lee	Sep 1999	A
5971938	Hart et al.	Oct 1999	A
5972019	Engelson et al.	Oct 1999	A
5974938	Lloyd	Nov 1999	A
5989233	Yoon	Nov 1999	A
5993483	Gianotti	Nov 1999	A
6030397	Moneti et al.	Feb 2000	A
6059814	Ladd	May 2000	A
6066158	Engelson et al.	May 2000	A
6068645	Tu	May 2000	A
6126635	Simpson et al.	Oct 2000	A
6142987	Tsugita	Nov 2000	A
6146396	Konya et al.	Nov 2000	A
6146403	St. Germain	Nov 2000	A
6152946	Broome et al.	Nov 2000	A
6156055	Ravenscroft	Dec 2000	A
6159230	Samuels	Dec 2000	A
6165196	Stack et al.	Dec 2000	A
6168579	Tsugita	Jan 2001	B1
6179859	Bates et al.	Jan 2001	B1
6221006	Dubrul et al.	Apr 2001	B1
6228060	Howell	May 2001	B1
6238412	Dubrul et al.	May 2001	B1
6245078	Ouchi	Jun 2001	B1
6245089	Daniel et al.	Jun 2001	B1
6254571	Hart	Jul 2001	B1
6258115	Dubrul	Jul 2001	B1
6264663	Cano	Jul 2001	B1
6306163	Fitz	Oct 2001	B1
6322572	Lee	Nov 2001	B1
6350271	Kurz et al.	Feb 2002	B1
6361545	Macoviak et al.	Mar 2002	B1
6364895	Greenhalgh	Apr 2002	B1
6368339	Amplatz	Apr 2002	B1
6383205	Samson et al.	May 2002	B1
6402771	Palmer et al.	Jun 2002	B1
6413235	Parodi	Jul 2002	B1
6423032	Parodi	Jul 2002	B2
6432122	Gilson et al.	Aug 2002	B1
6451036	Heitzmann et al.	Sep 2002	B1
6458103	Albert et al.	Oct 2002	B1
6475236	Roubin et al.	Nov 2002	B1
6485502	Don Michael	Nov 2002	B2
6508782	Evans et al.	Jan 2003	B1
6511492	Rosenbluth et al.	Jan 2003	B1
6514273	Voss et al.	Feb 2003	B1
6530923	Dubrul et al.	Mar 2003	B1
6530935	Wensel et al.	Mar 2003	B2
6544276	Azizi	Apr 2003	B1
6544278	Vrba et al.	Apr 2003	B1
6544279	Hopkins et al.	Apr 2003	B1
6551342	Shen et al.	Apr 2003	B1
6564828	Ishida	May 2003	B1
6569181	Burns	May 2003	B1
6575995	Huter et al.	Jun 2003	B1
6589263	Hopkins et al.	Jul 2003	B1
6596011	Johnson et al.	Jul 2003	B2
6602271	Adams et al.	Aug 2003	B2
6605074	Zadno-Azizi et al.	Aug 2003	B2
6605102	Mazzocchi et al.	Aug 2003	B1
6610077	Hancock et al.	Aug 2003	B1
6620148	Tsugita	Sep 2003	B1
6620179	Brook et al.	Sep 2003	B2
6620182	Khosravi et al.	Sep 2003	B1
6623460	Heck	Sep 2003	B1
6635068	Dubrul et al.	Oct 2003	B1
6645222	Parodi et al.	Nov 2003	B1
6660013	Rabiner et al.	Dec 2003	B2
6660014	Demarais et al.	Dec 2003	B2
6663650	Sepetka et al.	Dec 2003	B2
6692504	Kurz et al.	Feb 2004	B2
6699260	Dubrul et al.	Mar 2004	B2
6702830	Demarais et al.	Mar 2004	B1
6719717	Johnson et al.	Apr 2004	B1
6755847	Eskuri	Jun 2004	B2
6767353	Shiber	Jul 2004	B1
6790204	Zadno-Azizi et al.	Sep 2004	B2
6800080	Bates	Oct 2004	B1
6818006	Douk et al.	Nov 2004	B2
6824545	Sepetka et al.	Nov 2004	B2
6824550	Noriega et al.	Nov 2004	B1
6824553	Gene et al.	Nov 2004	B1
6830561	Jansen et al.	Dec 2004	B2
6846029	Ragner et al.	Jan 2005	B1
6902540	Dorros et al.	Jun 2005	B2
6939361	Kleshinski	Sep 2005	B1
6942682	Vrba et al.	Sep 2005	B2
6945977	Demarais et al.	Sep 2005	B2
6960189	Bates et al.	Nov 2005	B2
6960222	Vo et al.	Nov 2005	B2
7004931	Hogendijk	Feb 2006	B2
7004954	Voss et al.	Feb 2006	B1
7036707	Aota et al.	May 2006	B2
7041084	Fotjik	May 2006	B2
7052500	Bashiri et al.	May 2006	B2
7056328	Arnott	Jun 2006	B2
7063707	Bose et al.	Jun 2006	B2
7069835	Nishri et al.	Jul 2006	B2
7094249	Thomas et al.	Aug 2006	B1
7179273	Palmer et al.	Feb 2007	B1
7223253	Hogendijk	May 2007	B2
7232432	Fulton, III et al.	Jun 2007	B2
7244243	Lary	Jul 2007	B2
7285126	Sepetka et al.	Oct 2007	B2
7300458	Henkes et al.	Nov 2007	B2
7306618	Demond et al.	Dec 2007	B2
7320698	Eskuri	Jan 2008	B2
7323002	Johnson et al.	Jan 2008	B2
7331980	Dubrul et al.	Feb 2008	B2
7534234	Fotjik	May 2009	B2
7578830	Kusleika et al.	Aug 2009	B2
7621870	Berrada et al.	Nov 2009	B2
7674247	Fotjik	Mar 2010	B2
7691121	Rosenbluth et al.	Apr 2010	B2
7695458	Belley et al.	Apr 2010	B2
7763010	Evans et al.	Jul 2010	B2
7766934	Pal et al.	Aug 2010	B2
7775501	Kees	Aug 2010	B2
7780696	Daniel et al.	Aug 2010	B2
7905877	Oscar et al.	Mar 2011	B1
7905896	Straub	Mar 2011	B2
7938809	Lampropoulos et al.	May 2011	B2
7938820	Webster et al.	May 2011	B2
7967790	Whiting et al.	Jun 2011	B2
7976511	Fotjik	Jul 2011	B2
7993302	Hebert et al.	Aug 2011	B2
7993363	Demond et al.	Aug 2011	B2
8043313	Krolik et al.	Oct 2011	B2
8052640	Fiorella et al.	Nov 2011	B2
8057496	Fischer, Jr.	Nov 2011	B2
8057497	Raju et al.	Nov 2011	B1
8066757	Ferrera et al.	Nov 2011	B2
8070769	Broome	Dec 2011	B2
8070791	Ferrera et al.	Dec 2011	B2
8075510	Aklog et al.	Dec 2011	B2
8088140	Ferrera et al.	Jan 2012	B2
8092486	Berrada et al.	Jan 2012	B2
8100935	Rosenbluth et al.	Jan 2012	B2
8109962	Pal	Feb 2012	B2
8118829	Carrison et al.	Feb 2012	B2
8197493	Ferrera et al.	Jun 2012	B2
8246641	Osborne et al.	Aug 2012	B2
8261648	Marchand et al.	Sep 2012	B1
8267897	Wells	Sep 2012	B2
8298257	Sepetka et al.	Oct 2012	B2
8317748	Fiorella et al.	Nov 2012	B2
8337450	Fotjik	Dec 2012	B2
RE43902	Hopkins et al.	Jan 2013	E
8357178	Grandfield et al.	Jan 2013	B2
8361104	Jones et al.	Jan 2013	B2
8409215	Sepetka et al.	Apr 2013	B2
8486105	Demond et al.	Jul 2013	B2
8491539	Fotjik	Jul 2013	B2
8512352	Martin	Aug 2013	B2
8535283	Heaton et al.	Sep 2013	B2
8535334	Martin	Sep 2013	B2
8545526	Martin et al.	Oct 2013	B2
8568432	Straub	Oct 2013	B2
8574262	Ferrera et al.	Nov 2013	B2
8579915	French et al.	Nov 2013	B2
8585713	Ferrera et al.	Nov 2013	B2
8608754	Wensel et al.	Dec 2013	B2
8657867	Dorn et al.	Feb 2014	B2
8696622	Fiorella et al.	Apr 2014	B2
8715314	Janardhan et al.	May 2014	B1
8721714	Kelley	May 2014	B2
8753322	Hu et al.	Jun 2014	B2
8771289	Mohiuddin et al.	Jul 2014	B2
8777893	Malewicz	Jul 2014	B2
8784441	Rosenbluth et al.	Jul 2014	B2
8784442	Jones et al.	Jul 2014	B2
8795305	Martin et al.	Aug 2014	B2
8795345	Grandfield et al.	Aug 2014	B2
8801748	Martin	Aug 2014	B2
8808259	Walton et al.	Aug 2014	B2
8814927	Shin et al.	Aug 2014	B2
8820207	Marchand et al.	Sep 2014	B2
8826791	Thompson et al.	Sep 2014	B2
8828044	Aggerholm et al.	Sep 2014	B2
8833224	Thompson et al.	Sep 2014	B2
8845621	Fotjik	Sep 2014	B2
8852226	Gilson et al.	Oct 2014	B2
8939991	Krolik et al.	Jan 2015	B2
8945143	Ferrera et al.	Feb 2015	B2
8945172	Ferrera et al.	Feb 2015	B2
8956384	Berrada et al.	Feb 2015	B2
8992504	Castella et al.	Mar 2015	B2
9005172	Chung	Apr 2015	B2
9028401	Bacich et al.	May 2015	B1
9078682	Lenker et al.	Jul 2015	B2
9101382	Krolik et al.	Aug 2015	B2
9125683	Farhangnia et al.	Sep 2015	B2
9126016	Fulton	Sep 2015	B2
9149609	Ansel et al.	Oct 2015	B2
9155552	Ulm, III	Oct 2015	B2
9161766	Slee et al.	Oct 2015	B2
9173668	Ulm, III	Nov 2015	B2
9186487	Dubrul et al.	Nov 2015	B2
9204887	Cully et al.	Dec 2015	B2
9216277	Myers	Dec 2015	B2
9358037	Farhangnia et al.	Jan 2016	B2
9259237	Quick et al.	Feb 2016	B2
9283066	Hopkins et al.	Mar 2016	B2
9351747	Kugler et al.	May 2016	B2
9439664	Sos	Sep 2016	B2
9439751	White et al.	Sep 2016	B2
9456834	Folk	Oct 2016	B2
9463035	Greenhalgh et al.	Oct 2016	B1
9463036	Brady et al.	Oct 2016	B2
9526864	Quick	Dec 2016	B2
9526865	Quick	Dec 2016	B2
9566424	Pessin	Feb 2017	B2
9579116	Nguyen et al.	Feb 2017	B1
9616213	Furnish et al.	Apr 2017	B2
9636206	Nguyen et al.	May 2017	B2
9643035	Mastenbroek	May 2017	B2
9700332	Marchand et al.	Jul 2017	B2
9717514	Martin et al.	Aug 2017	B2
9717519	Rosenbluth et al.	Aug 2017	B2
9744024	Nguyen et al.	Aug 2017	B2
9757137	Krolik et al.	Sep 2017	B2
9827084	Bonnette et al.	Nov 2017	B2
9844386	Nguyen et al.	Dec 2017	B2
9844387	Marchand et al.	Dec 2017	B2
9848975	Hauser	Dec 2017	B2
9849014	Kusleika	Dec 2017	B2
9962178	Greenhalgh et al.	May 2018	B2
9980813	Eller	May 2018	B2
9999493	Nguyen et al.	Jun 2018	B2
10004531	Rosenbluth et al.	Jun 2018	B2
10010335	Greenhalgh et al.	Jul 2018	B2
10016266	Hauser	Jul 2018	B2
10028759	Wallace et al.	Jul 2018	B2
10045790	Cox et al.	Aug 2018	B2
10098651	Marchand et al.	Oct 2018	B2
10130385	Farhangnia et al.	Nov 2018	B2
10226263	Look et al.	Mar 2019	B2
10238406	Cox et al.	Mar 2019	B2
10271864	Greenhalgh et al.	Apr 2019	B2
10327883	Yachia	Jun 2019	B2
10335186	Rosenbluth et al.	Jul 2019	B2
10342571	Marchand et al.	Jul 2019	B2
10349960	Quick	Jul 2019	B2
10383644	Molaei et al.	Aug 2019	B2
10478535	Ogle	Nov 2019	B2
10524811	Marchand et al.	Jan 2020	B2
10588655	Rosenbluth et al.	Mar 2020	B2
10695159	Hauser	Jun 2020	B2
10709471	Rosenbluth et al.	Jul 2020	B2
10799331	Hauser	Oct 2020	B2
10912577	Marchand et al.	Feb 2021	B2
11000682	Merritt et al.	May 2021	B2
11013523	Arad Hadar	May 2021	B2
11058445	Cox et al.	Jul 2021	B2
11058451	Marchand et al.	Jul 2021	B2
11147571	Cox et al.	Oct 2021	B2
11154314	Quick	Oct 2021	B2
11259821	Buck et al.	Mar 2022	B2
11406801	Fojtik et al.	Aug 2022	B2
11433218	Quick et al.	Sep 2022	B2
11439799	Buck et al.	Sep 2022	B2
11457936	Buck et al.	Oct 2022	B2
11529158	Hauser	Dec 2022	B2
11554005	Merritt et al.	Jan 2023	B2
11559382	Merritt et al.	Jan 2023	B2
20010004699	Gittings et al.	Jun 2001	A1
20010031981	Evans et al.	Oct 2001	A1
20010041909	Tsugita et al.	Nov 2001	A1
20010049486	Evans et al.	Dec 2001	A1
20010051810	Dubrul et al.	Dec 2001	A1
20020022858	Demond et al.	Feb 2002	A1
20020022859	Hogendijk	Feb 2002	A1
20020026211	Khosravi et al.	Feb 2002	A1
20020032455	Boock et al.	Mar 2002	A1
20020049452	Kurz et al.	Apr 2002	A1
20020095161	Dhindsa	Jul 2002	A1
20020095171	Belef	Jul 2002	A1
20020111648	Kusleika et al.	Aug 2002	A1
20020120277	Hauschild et al.	Aug 2002	A1
20020147458	Hiblar et al.	Oct 2002	A1
20020151918	Lafontaine et al.	Oct 2002	A1
20020156457	Fisher	Oct 2002	A1
20020161392	Dubrul	Oct 2002	A1
20020169474	Kusleika	Nov 2002	A1
20020173819	Leeflang et al.	Nov 2002	A1
20020188276	Evans et al.	Dec 2002	A1
20030083693	Daniel et al.	May 2003	A1
20030100919	Hopkins et al.	May 2003	A1
20030114875	Sjostrom	Jun 2003	A1
20030116731	Hartley	Jun 2003	A1
20030125663	Coleman et al.	Jul 2003	A1
20030135230	Massey et al.	Jul 2003	A1
20030135258	Andreas et al.	Jul 2003	A1
20030153873	Luther et al.	Aug 2003	A1
20030153973	Soun et al.	Aug 2003	A1
20030168068	Poole et al.	Sep 2003	A1
20030176884	Berrada et al.	Sep 2003	A1
20030191516	Weldon et al.	Oct 2003	A1
20030208224	Broome	Nov 2003	A1
20030216774	Larson	Nov 2003	A1
20040039412	Isshiki et al.	Feb 2004	A1
20040068288	Palmer et al.	Apr 2004	A1
20040073243	Sepetka et al.	Apr 2004	A1
20040098033	Leeflang et al.	May 2004	A1
20040102807	Kusleika et al.	May 2004	A1
20040122359	Wenz et al.	Jun 2004	A1
20040127936	Salahieh et al.	Jul 2004	A1
20040133232	Rosenbluth et al.	Jul 2004	A1
20040138525	Saadat et al.	Jul 2004	A1
20040138692	Phung et al.	Jul 2004	A1
20040167567	Cano et al.	Aug 2004	A1
20040199201	Kellett et al.	Oct 2004	A1
20040199202	Dubrul et al.	Oct 2004	A1
20040260344	Lyons et al.	Dec 2004	A1
20040267272	Henniges et al.	Dec 2004	A1
20050033172	Dubrul et al.	Feb 2005	A1
20050038468	Panetta et al.	Feb 2005	A1
20050054995	Barzell et al.	Mar 2005	A1
20050055047	Greenhalgh	Mar 2005	A1
20050085769	MacMahon et al.	Apr 2005	A1
20050085826	Nair et al.	Apr 2005	A1
20050085846	Carrison et al.	Apr 2005	A1
20050085849	Sepetka et al.	Apr 2005	A1
20050119668	Teague et al.	Jun 2005	A1
20050177132	Lentz et al.	Aug 2005	A1
20050187570	Nguyen et al.	Aug 2005	A1
20050283165	Gadberry	Dec 2005	A1
20050283166	Greenhalgh et al.	Dec 2005	A1
20050283186	Berrada et al.	Dec 2005	A1
20060020286	Niermann	Jan 2006	A1
20060042786	West	Mar 2006	A1
20060047286	West	Mar 2006	A1
20060074401	Ross	Apr 2006	A1
20060089533	Ziegler et al.	Apr 2006	A1
20060100662	Daniel et al.	May 2006	A1
20060155305	Freudenthal et al.	Jul 2006	A1
20060173525	Behl et al.	Aug 2006	A1
20060195137	Sepetka et al.	Aug 2006	A1
20060200221	Malewicz	Sep 2006	A1
20060217664	Hattier et al.	Sep 2006	A1
20060224177	Finitsis	Oct 2006	A1
20060229645	Bonnette et al.	Oct 2006	A1
20060247500	Voegele et al.	Nov 2006	A1
20060253145	Lucas	Nov 2006	A1
20060276874	Wilson et al.	Dec 2006	A1
20060282111	Morsi	Dec 2006	A1
20060293696	Fahey et al.	Dec 2006	A1
20070010787	Hackett et al.	Jan 2007	A1
20070038225	Osborne	Feb 2007	A1
20070093744	Elmaleh	Apr 2007	A1
20070112374	Paul, Jr. et al.	May 2007	A1
20070118165	DeMello et al.	May 2007	A1
20070149996	Coughlin	Jun 2007	A1
20070161963	Smalling	Jul 2007	A1
20070179513	Deutsch	Aug 2007	A1
20070191866	Palmer et al.	Aug 2007	A1
20070198028	Miloslavski et al.	Aug 2007	A1
20070208361	Okushi et al.	Sep 2007	A1
20070208367	Fiorella et al.	Sep 2007	A1
20070213753	Waller	Sep 2007	A1
20070213765	Adams et al.	Sep 2007	A1
20070255252	Mehta	Nov 2007	A1
20070288054	Tanaka et al.	Dec 2007	A1
20080015541	Rosenbluth et al.	Jan 2008	A1
20080088055	Ross	Apr 2008	A1
20080157017	Macatangay et al.	Jul 2008	A1
20080167678	Morsi	Jul 2008	A1
20080183136	Lenker et al.	Jul 2008	A1
20080228209	DeMello et al.	Sep 2008	A1
20080234715	Pesce et al.	Sep 2008	A1
20080234722	Bonnette et al.	Sep 2008	A1
20080262528	Martin	Oct 2008	A1
20080269798	Ramzipoor et al.	Oct 2008	A1
20080300466	Gresham	Dec 2008	A1
20090018566	Escudero et al.	Jan 2009	A1
20090054918	Henson	Feb 2009	A1
20090062841	Amplatz et al.	Mar 2009	A1
20090069828	Martin et al.	Mar 2009	A1
20090076417	Jones	Mar 2009	A1
20090160112	Ostrovsky	Jun 2009	A1
20090163846	Aklog et al.	Jun 2009	A1
20090182362	Thompson et al.	Jul 2009	A1
20090192495	Ostrovsky et al.	Jul 2009	A1
20090281525	Harding et al.	Nov 2009	A1
20090292307	Razack	Nov 2009	A1
20090299393	Martin et al.	Dec 2009	A1
20100016837	Howat	Jan 2010	A1
20100030256	Dubrul et al.	Feb 2010	A1
20100042136	Berrada et al.	Feb 2010	A1
20100087844	Fischer, Jr.	Apr 2010	A1
20100087850	Razack	Apr 2010	A1
20100114113	Dubrul et al.	May 2010	A1
20100121312	Gielenz et al.	May 2010	A1
20100137846	Desai et al.	Jun 2010	A1
20100190156	Van Wordragen et al.	Jul 2010	A1
20100204712	Mallaby	Aug 2010	A1
20100217276	Garrison et al.	Aug 2010	A1
20100249815	Jantzen et al.	Sep 2010	A1
20100268264	Bonnette et al.	Oct 2010	A1
20100318178	Rapaport et al.	Dec 2010	A1
20110034986	Chou et al.	Feb 2011	A1
20110034987	Kennedy	Feb 2011	A1
20110054405	Whiting et al.	Mar 2011	A1
20110060212	Slee et al.	Mar 2011	A1
20110118817	Gunderson et al.	May 2011	A1
20110125181	Brady et al.	May 2011	A1
20110144592	Wong	Jun 2011	A1
20110152823	Mohiuddin et al.	Jun 2011	A1
20110152993	Marchand et al.	Jun 2011	A1
20110160742	Ferrera et al.	Jun 2011	A1
20110160763	Ferrera et al.	Jun 2011	A1
20110190806	Wittens	Aug 2011	A1
20110196309	Wells	Aug 2011	A1
20110196414	Porter et al.	Aug 2011	A1
20110213290	Chin et al.	Sep 2011	A1
20110213403	Aboytes	Sep 2011	A1
20110224707	Miloslavski et al.	Sep 2011	A1
20110245807	Sakata et al.	Oct 2011	A1
20110251629	Galdonik et al.	Oct 2011	A1
20110264133	Hanlon et al.	Oct 2011	A1
20110265681	Allen et al.	Nov 2011	A1
20110288529	Fulton	Nov 2011	A1
20110288572	Martin	Nov 2011	A1
20110319917	Ferrera et al.	Dec 2011	A1
20120059309	di Palma et al.	Mar 2012	A1
20120059356	di Palma et al.	Mar 2012	A1
20120083824	Berrada et al.	Apr 2012	A1
20120083868	Shrivastava	Apr 2012	A1
20120089216	Rapaport et al.	Apr 2012	A1
20120101480	Ingle et al.	Apr 2012	A1
20120101510	Lenker et al.	Apr 2012	A1
20120138832	Townsend	Jun 2012	A1
20120143239	Aklog et al.	Jun 2012	A1
20120165919	Cox et al.	Jun 2012	A1
20120172918	Fifer et al.	Jul 2012	A1
20120179181	Straub et al.	Jul 2012	A1
20120197277	Stinis	Aug 2012	A1
20120232655	Lorrison et al.	Sep 2012	A1
20120271105	Nakamura et al.	Oct 2012	A1
20120271231	Agrawal	Oct 2012	A1
20120277788	Cattaneo	Nov 2012	A1
20120310166	Huff	Dec 2012	A1
20130030460	Marks et al.	Jan 2013	A1
20130035628	Garrison et al.	Feb 2013	A1
20130046332	Jones et al.	Feb 2013	A1
20130066348	Fiorella et al.	Mar 2013	A1
20130092012	Marchand et al.	Apr 2013	A1
20130096571	Massicotte et al.	Apr 2013	A1
20130102996	Strauss	Apr 2013	A1
20130116708	Ziniti et al.	May 2013	A1
20130116721	Takagi et al.	May 2013	A1
20130126559	Cowan et al.	May 2013	A1
20130144326	Brady et al.	Jun 2013	A1
20130165871	Fiorella et al.	Jun 2013	A1
20130184703	Shireman et al.	Jul 2013	A1
20130197454	Shibata et al.	Aug 2013	A1
20130197567	Brady et al.	Aug 2013	A1
20130226196	Smith	Aug 2013	A1
20130281788	Garrison	Oct 2013	A1
20130289608	Tanaka et al.	Oct 2013	A1
20130317589	Martin et al.	Nov 2013	A1
20130345739	Brady et al.	Dec 2013	A1
20140005712	Martin	Jan 2014	A1
20140005713	Bowman	Jan 2014	A1
20140005715	Castella et al.	Jan 2014	A1
20140005717	Martin et al.	Jan 2014	A1
20140025048	Ward	Jan 2014	A1
20140031856	Martin	Jan 2014	A1
20140046133	Nakamura et al.	Feb 2014	A1
20140046243	Ray et al.	Feb 2014	A1
20140052161	Cully et al.	Feb 2014	A1
20140074144	Shrivastava et al.	Mar 2014	A1
20140121672	Folk	May 2014	A1
20140155830	Bonnette et al.	Jun 2014	A1
20140155980	Turjman	Jun 2014	A1
20140180397	Gerberding et al.	Jun 2014	A1
20140155908	Rosenbluth et al.	Jul 2014	A1
20140188127	Dubrul et al.	Jul 2014	A1
20140188143	Martin et al.	Jul 2014	A1
20140236219	Dubrul et al.	Aug 2014	A1
20140243882	Ma	Aug 2014	A1
20140257253	Jemison	Sep 2014	A1
20140257363	Lippert	Sep 2014	A1
20140276403	Follmer et al.	Sep 2014	A1
20140296868	Garrison et al.	Oct 2014	A1
20140303658	Bonnette et al.	Oct 2014	A1
20140318354	Thompson et al.	Oct 2014	A1
20140324091	Rosenbluth	Oct 2014	A1
20140330286	Wallace et al.	Nov 2014	A1
20140336691	Jones et al.	Nov 2014	A1
20140343593	Chin et al.	Nov 2014	A1
20140364896	Consigny	Dec 2014	A1
20140371779	Vale et al.	Dec 2014	A1
20150005781	Lund-Clausen et al.	Jan 2015	A1
20150005792	Ahn	Jan 2015	A1
20150018859	Quick	Jan 2015	A1
20150018860	Quick	Jan 2015	A1
20150018929	Martin et al.	Jan 2015	A1
20150025555	Sos	Jan 2015	A1
20150032144	Holloway	Jan 2015	A1
20150059908	Mollen	Mar 2015	A1
20150088190	Jensen	Mar 2015	A1
20150127035	Trapp et al.	May 2015	A1
20150133990	Davidson	May 2015	A1
20150150672	Ma	Jun 2015	A1
20150164523	Brady et al.	Jun 2015	A1
20150164666	Johnson et al.	Jun 2015	A1
20150173782	Garrison et al.	Jun 2015	A1
20150190155	Ulm, III	Jul 2015	A1
20150190156	Ulm, III	Jul 2015	A1
20150196380	Berrada et al.	Jul 2015	A1
20150196744	Aboytes	Jul 2015	A1
20150209058	Ferrera et al.	Jul 2015	A1
20150209165	Grandfield et al.	Jul 2015	A1
20150238207	Cox et al.	Aug 2015	A1
20150250578	Cook et al.	Sep 2015	A1
20150265299	Cooper et al.	Sep 2015	A1
20150305756	Rosenbluth	Oct 2015	A1
20150305859	Eller	Oct 2015	A1
20150352325	Quick	Dec 2015	A1
20150360001	Quick	Dec 2015	A1
20150374391	Quick	Dec 2015	A1
20160022293	Dubrul et al.	Jan 2016	A1
20160058540	Don Michael	Mar 2016	A1
20160074627	Cottone	Mar 2016	A1
20160106448	Brady et al.	Apr 2016	A1
20160106449	Brady et al.	Apr 2016	A1
20160113663	Brady et al.	Apr 2016	A1
20160113664	Brady et al.	Apr 2016	A1
20160113665	Brady et al.	Apr 2016	A1
20160113666	Quick	Apr 2016	A1
20160143721	Rosenbluth	May 2016	A1
20160151605	Welch et al.	Jun 2016	A1
20160206344	Bruzzi et al.	Jul 2016	A1
20160008014	Rosenbluth	Aug 2016	A1
20160220741	Garrison et al.	Aug 2016	A1
20160228134	Martin et al.	Aug 2016	A1
20160262774	Honda	Sep 2016	A1
20160262790	Rosenbluth et al.	Sep 2016	A1
20160287276	Cox et al.	Oct 2016	A1
20160367285	Sos	Dec 2016	A1
20170014560	Minskoff et al.	Jan 2017	A1
20170037548	Lee	Feb 2017	A1
20170042571	Levi	Feb 2017	A1
20170049942	Conlan et al.	Feb 2017	A1
20170056032	Look et al.	Mar 2017	A1
20170058623	Jaffrey et al.	Mar 2017	A1
20170079672	Quick	Mar 2017	A1
20170086864	Greenhalgh et al.	Mar 2017	A1
20170100142	Look et al.	Apr 2017	A1
20170105743	Vale et al.	Apr 2017	A1
20170105745	Rosenbluth et al.	Apr 2017	A1
20170112514	Marchand et al.	Apr 2017	A1
20170112513	Marchand et al.	Jul 2017	A1
20170189041	Cox et al.	Jul 2017	A1
20170196576	Long et al.	Jul 2017	A1
20170233908	Kroczynski et al.	Aug 2017	A1
20170252057	Bonnette et al.	Sep 2017	A1
20170265878	Marchand et al.	Sep 2017	A1
20170303939	Greenhalgh et al.	Oct 2017	A1
20170303942	Greenhalgh et al.	Oct 2017	A1
20170303947	Greenhalgh et al.	Oct 2017	A1
20170303948	Wallace et al.	Oct 2017	A1
20170319221	Chu	Nov 2017	A1
20170325839	Rosenbluth et al.	Nov 2017	A1
20170340867	Accisano, II	Nov 2017	A1
20170348014	Wallace et al.	Dec 2017	A1
20180042623	Batiste	Feb 2018	A1
20180042624	Greenhalgh et al.	Feb 2018	A1
20180042626	Greenhalgh et al.	Feb 2018	A1
20180064453	Garrison et al.	Mar 2018	A1
20180064454	Losordo et al.	Mar 2018	A1
20180070968	Wallace et al.	Mar 2018	A1
20180092652	Marchand et al.	Apr 2018	A1
20180104404	Ngo-Chu	Apr 2018	A1
20180105963	Quick	Apr 2018	A1
20180125512	Nguyen et al.	May 2018	A1
20180184912	Al-Ali	Jul 2018	A1
20180193043	Marchand et al.	Jul 2018	A1
20180236205	Krautkremer et al.	Aug 2018	A1
20180256177	Cooper et al.	Sep 2018	A1
20180256178	Cox et al.	Sep 2018	A1
20180296240	Rosenbluth et al.	Oct 2018	A1
20180344339	Cox et al.	Dec 2018	A1
20180361116	Quick et al.	Dec 2018	A1
20190000492	Casey et al.	Jan 2019	A1
20190046219	Marchand et al.	Feb 2019	A1
20190070401	Merritt et al.	Mar 2019	A1
20190117244	Wallace et al.	Apr 2019	A1
20190133622	Wallace et al.	May 2019	A1
20190133623	Wallace et al.	May 2019	A1
20190133624	Wallace et al.	May 2019	A1
20190133625	Wallace et al.	May 2019	A1
20190133626	Wallace et al.	May 2019	A1
20190133627	Wallace et al.	May 2019	A1
20190150959	Cox et al.	May 2019	A1
20190231373	Quick	Aug 2019	A1
20190239910	Brady et al.	Aug 2019	A1
20190321071	Marchand et al.	Oct 2019	A1
20190336142	Torrie et al.	Nov 2019	A1
20190336148	Greenhalgh et al.	Nov 2019	A1
20200046368	Merritt et al.	Feb 2020	A1
20200113412	Jensen	Apr 2020	A1
20210022843	Hauser	Jan 2021	A1
20210113224	Dinh	Apr 2021	A1
20210137667	Sonnette et al.	May 2021	A1
20210186541	Thress	Jun 2021	A1
20210236148	Marchand et al.	Aug 2021	A1
20210290925	Merritt et al.	Sep 2021	A1
20210315598	Buck et al.	Oct 2021	A1
20210330344	Rosenbluth et al.	Oct 2021	A1
20210378694	Thress et al.	Dec 2021	A1
20220000505	Hauser	Jan 2022	A1
20220000506	Hauser	Jan 2022	A1
20220000507	Hauser	Jan 2022	A1
20220015798	Marchand et al.	Jan 2022	A1
20220022898	Cox et al.	Jan 2022	A1
20220039815	Thress et al.	Feb 2022	A1
20220125451	Hauser	Apr 2022	A1
20220142638	Enright et al.	May 2022	A1
20220151647	Dolendo et al.	May 2022	A1
20220152355	Dolendo et al.	May 2022	A1
20220160381	Hauser	May 2022	A1
20220160382	Hauser	May 2022	A1
20220160383	Hauser	May 2022	A1
20220211400	Cox et al.	Jul 2022	A1
20220211992	Merritt et al.	Jul 2022	A1
20220240959	Quick	Aug 2022	A1
20220346800	Merritt et al.	Nov 2022	A1
20220346801	Merritt et al.	Nov 2022	A1
20220346813	Quick	Nov 2022	A1
20220346814	Quick	Nov 2022	A1
20220362512	Quick et al.	Nov 2022	A1
20230046775	Quick	Feb 2023	A1
20230062809	Merritt et al.	Mar 2023	A1
20230070120	Cox et al.	Mar 2023	A1

Foreign Referenced Citations (89)

Number	Date	Country
2015210338	Aug 2015	AU
102186427	Sep 2011	CN
103764049	Apr 2014	CN
103932756	Jul 2014	CN
104068910	Oct 2014	CN
108348319	Jul 2018	CN
110652645	Jan 2020	CN
111281482	Jun 2020	CN
102017004383	Jul 2018	DE
1254634	Nov 2002	EP
1867290	Feb 2013	EP
1588072	Apr 1981	GB
2498349	Jul 2013	GB
H6190049	Jul 1994	JP
H07323090	Dec 1995	JP
2001522631	May 1999	JP
2004097807	Apr 2004	JP
2005-095242	Jun 2005	JP
2005230132	Sep 2005	JP
2005323702	Nov 2005	JP
2006094876	Apr 2006	JP
2011526820	Jan 2010	JP
WO1997017889	May 1997	WO
WO9833443	Aug 1998	WO
WO9838920	Sep 1998	WO
WO9839053	Sep 1998	WO
WO9851237	Nov 1998	WO
WO1999044542	Sep 1999	WO
WO0032118	Jun 2000	WO
WO2000053120	Sep 2000	WO
WO0202162	Jan 2002	WO
WO03015840	Feb 2003	WO
WO2004018916	Mar 2004	WO
W02004093696	Nov 2004	WO
WO2005046736	May 2005	WO
WO2006110186	Oct 2006	WO
WO2006124307	Nov 2006	WO
WO2007092820	Aug 2007	WO
WO2009082513	Jul 2009	WO
WO2009086482	Jul 2009	WO
WO2009155571	Dec 2009	WO
WO2010002549	Jan 2010	WO
WO2010010545	Jan 2010	WO
WO2010023671	Mar 2010	WO
WO2010049121	May 2010	WO
WO2010102307	Sep 2010	WO
WO2011032712	Mar 2011	WO
WO2011054531	May 2011	WO
WO2011073176	Jun 2011	WO
W02012011097	Jan 2012	WO
WO2012009675	Jan 2012	WO
WO2012049652	Apr 2012	WO
WO2012065748	May 2012	WO
WO2012120490	Sep 2012	WO
WO2012162437	Nov 2012	WO
WO2014047650	Mar 2014	WO
WO2014081892	May 2014	WO
WO2015006782	Jan 2015	WO
WO2015061365	Apr 2015	WO
WO2015121424	Aug 2015	WO
W02015191646	Dec 2015	WO
WO2015189354	Dec 2015	WO
W02017024258	Feb 2017	WO
W02017070702	Apr 2017	WO
WO2017058280	Apr 2017	WO
WO2017106877	Jun 2017	WO
WO2017189535	Nov 2017	WO
WO2017189550	Nov 2017	WO
WO2017189591	Nov 2017	WO
WO2017189615	Nov 2017	WO
WO2017210487	Dec 2017	WO
WO2018049317	Mar 2018	WO
W02018080590	May 2018	WO
WO2018148174	Aug 2018	WO
WO2019010318	Jan 2019	WO
W02019050765	Mar 2019	WO
W02019075444	Apr 2019	WO
WO2019094456	May 2019	WO
WO2019222117	Nov 2019	WO
WO2019246240	Dec 2019	WO
WO2020036809	Feb 2020	WO
WO2021067134	Apr 2021	WO
WO2021076954	Apr 2021	WO
WO2021127202	Jun 2021	WO
WO2021248042	Dec 2021	WO
WO2022032173	Feb 2022	WO
WO2022103848	May 2022	WO
WO2022109021	May 2022	WO
WO2022109034	May 2022	WO

Non-Patent Literature Citations (85)

Entry
European Patent Application No. 13838945.7, Extended European Search Report, 9 pages, dated Apr. 15, 2016.
Gibbs, et al., “Temporary Stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience,” British Heart Journal, 1994, 71:372-377, Oct. 12, 1993, 6 pgs.
Gupta, S. et al., “Acute Pulmonary Embolism Advances in Treatment”, JAPI, Association of Physicians India, Mar. 2008, vol. 56, 185-191.
International Search Report and Written Opinion for International App. No. PCT/US13/61470, dated Jan. 17, 2014, 7 pages.
International Search Report and Written Opinion for International App. No. PCT/US2014/046567, dated Nov. 3, 2014, 13 pages.
International Search Report and Written Opinion for International App. No. PCT/US2014/061645, dated Jan. 23, 2015, 15 pages.
International Search Report for International App. No. PCT/US13/71101, dated Mar. 31, 2014, 4 pages.
Konstantinides, S. et al., “Pulmonary embolism hotline 2012—Recent and expected trials”, Thrombosis and Haemostasis, Jan. 9, 2013:33; 43-50.
Konstantinides, S. et al., “Pulmonary embolism: risk assessment and management”, European Society of Cardiology; European Heart Journal, Sep. 7, 2012:33, 3014-3022.
Kucher, N. et al., “Percutaneous Catheter Thrombectomy Device for Acute Pulmonary Embolism: In Vitro and in Vivo Testing”, Circulation, Sep. 2005:112:e28-e32.
Kucher, N., “Catheter Interventions in Massive Pulmonary Embolism”, Cardiology Rounds, Mar. 2006 vol. 10, Issue 3, 6 pages.
Kucher, N. et al., “Management of Massive Pulmonary Embolism”, Radiology, Sep. 2005:236:3 852-858.
Kucher, N. et al., “Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism.” Circulation, 2014, 129, pages 9 pages.
Kuo, W. et al., “Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques”, Journal of Vascular and Interventional Radiology, Nov. 2009:20:1431-1440.
Kuo, W. et al., “Catheter-Directed Embolectomy, Fragmentation, and Thrombolysis for the Treatment of Massive Pulmonary Embolism After Failure of Systemic Thrombolysis”, American College of CHEST Physicians 2008: 134:250-254.
Kuo, W. Md, “Endovascular Therapy for Acute Pulmonary Embolism”, Continuing Medical Education Society of Interventional Radiology (“CME”); Journal of Vascular and Interventional Radiology, Feb. 2012: 23:167-179.
Lee, L. et al, “Massive pulmonary embolism: review of management strategies with a focus on catheter-based techniques”, Expert Rev. Cardiovasc. Ther. 8(6), 863-873 (2010).
Liu, S. et al, “Massive Pulmonary Embolism: Treatment with the Rotarex Thrombectomy System”, Cardiovascular Interventional Radiology; 2011: 34:106-113.
Muller-Hulsbeck, S. et al. “Mechanical Thrombectomy of Major and Massive Pulmonary Embolism with Use of the Amplatz Thrombectomy Device”, Investigative Radiology, Jun. 2001:36:6:317-322.
Reekers, J. et al., “Mechanical Thrombectomy for Early Treatment of Massive Pulmonary Embolism”, CardioVascular and Interventional Radiology, 2003: 26:246-250.
Schmitz-Rode et al., “New Mesh Basket for Percutaneous Removal of Wall-Adherent Thrombi in Dialysis Shunts,” Cardiovasc Intervent Radiol 16:7-10 1993 4 pgs.
Schmitz-Rode et al., “Temporary Pulmonary Stent Placement as Emergency Treatment of Pulmonary Embolism,” Journal of the American College of Cardiology, vol. 48, No. 4, 2006 (5 pgs.).
Schmitz-Rode, T. et al., “Massive Pulmonary Embolism: Percutaneous Emergency Treatment by Pigtail Rotation Catheter”, JACC Journal of the American College of Cardiology, Aug. 2000:36:2:375-380.
Spiotta, A et al., “Evolution of thrombectomy approaches and devices for acute stroke: a technical review.” J NeuroIntervent Surg 2015, 7, pages 7 pages.
Svilaas, T. et al., “Thrombus Aspiration During Primary Percutaneous Coronary Intervention.” The New England Journal of Medicine, 2008, vol. 358, No. 6, 11 pages.
Tapson, V., “Acute Pulmonary Embolism”, The New England Journal of Medicine, Mar. 6, 2008:358:2037-52.
The Penumbra Pivotal Stroke Trial Investigators, “The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease.” Stroke, 2009, 40: page 9 pages.
Truong et al., “Mechanical Thrombectomy of Iliocaval Thrombosis Using a Protective Expandable Sheath,” Cardiovasc Intervent Radiol27-254-258, 2004, 5 pgs.
Turk et al., “Adapt Fast study: a direct aspiration first pass technique for acute stroke thrombectomy.” J NeuroIntervent Surg, vol. 6, 2014, 6 pages.
Uflacker, R., “Interventional Therapy for Pulmonary Embolism”, Journal of Vascular and Interventional Radiology, Feb. 2001: 12:147-164.
Verma, R., Md et al. “Evaluation of a Newly Developed Percutaneous Thrombectomy Basket Device in Sheep With Central Pulmonary Embolisms”, Investigative Radiology, Oct. 2006, 41, 729-734.
International Search Report and Written Opinion for International App. No. PCT/US2015/034987 filed Jun. 9, 2015, Applicant: Inceptus Medical, LLC, dated Sep. 17, 2015, 12 pages.
English translation of Japanese Office Action received for JP Application No. 2016-564210, Applicant: Inceptus Medical, LLC, dated Sep. 4, 2017, 4 pages.
Australian Exam Report received for AU Application No. 2015274704, Applicant: Inceptus Medical, LLC, dated Sep. 7, 2017, 3 pages.
European Search Report received for EP Application No. 15805810.7, Applicant: Inceptus Medical, LLC, dated Sep. 4, 2017, 6 pages.
International Search Report and Written Opinion for International App. No. PCT/US2016/067628 filed Dec. 19, 2016, Applicant: Inari Medical, Inc., dated Apr. 10, 2017, 11 pages.
Goldhaber, S. et al. “Percutaneous Mechanical Thrombectomy for Acute Pulmonary Embolism—A Double-Edged Sword,” American College of CHEST Physicians, Aug. 2007, 132:2, 363-372.
Goldhaber, S., “Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy,” Journal of Thrombosis and Haemostasis, 2009: 7 (Suppl. 1): 322-327.
International Search Report and Written Opinion for International App. No. PCT/US2017/029696, Date of Filing: Apr. 26, 2017, Applicant: Inari Medical, Inc., dated Sep. 15, 2017, 19 pages.
International Search Report and Written Opinion for International App. No. PCT/US2016/058536, Date of Filing: Oct. 24, 2016, Applicant: Inari Medical, Inc., dated Mar. 13, 2017, 14 pages.
European First Office Action received for EP Application No. 13838945.7, Applicant: Inari Medical, Inc., dated Oct. 26, 2018, 7 pages.
International Search Report and Written Opinion for International App. No. PCT/US2018/048786, Date of Filing: Aug. 30, 2018, Applicant: Inari Medical, Inc., dated Dec. 13, 2018, 12 pages.
International Search Report and Written Opinion for International App. No. PCT/US2018/055780, Date of Filing: Oct. 13, 2018, Applicant: Inceptus Medical LLC., dated Jan. 22, 2019, 8 pages.
European Search Report for European Application No. 16876941.2, Date of Filing: Dec. 19, 2016, Applicant: Inari Medical, Inc., dated Jul. 18, 2019, 7 pages.
Extended European Search Report for European Application No. 16858462.1, Date of Filing: Oct. 24, 2016, Applicant: Inari Medical, Inc., dated Jun. 3, 2019, 10 pages.
International Search Report and Written Opinion for International App. No. PCT/US2019/045794, Date of Filing: Aug. 8, 2019, Applicant: Inari Medical, Inc., dated Nov. 1, 2019, 17 pages.
Partial Supplementary European Search Report for European Application No. 17864818.4, Date of Filing: May 21, 2019, Applicant: Inari Medical, Inc., dated Apr. 24, 2020, 11 pages.
International Search Report and Written Opinion for International App. No. PCT/US2020/056067, Date of Filing: Oct. 16, 2020; Applicant: Inari Medical, Inc., dated Jan. 22, 2021, 8 pages.
Extended European Search Report for European Application No. 20191581.6, Applicant: Inari Medical, Inc., dated Mar. 31, 2021, 11 pages.
International Search Report and Written Opinion for International App. No. PCT/US2020/055645, Date of Filing: Dec. 17, 2020; Applicant: Inari Medical, Inc., dated Apr. 14, 2021, 12 pages.
Extended European Search Report for European Application No. 18853465.5, Applicant: Inari Medical, Inc., Date of Mailing: May 7, 2021, 2021, 7 pages.
Vorwerk, D. Md, et al., “Use of a Temporary Caval Filter to Assist Percutaneous Iliocaval Thrombectomy: Experimental Results.” SCVIR, 1995, 4 pages.
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2020/014854, dated Oct. 5, 2020 (13 pages).
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2020/018655, dated Dec. 16, 2020 (22 pages).
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2020/017684, dated Nov. 30, 2020 (19 pages).
Extended European Search Report for EP Patent Appln. No. 20185092.2 dated Sep. 11, 2020, 6 pages.
EP Examination Report for EP Patent Appln. No. 18745794.0 dated Jul. 20, 2020, 4 pages.
Wikipedia; Embolectomy; retrieved from the internet: https://en.wikipedia.org/wiki/Embolectomy; 4 pgs.; retrieved/printed: Mar. 24, 2016.
O'Sullivan; Thrombolysis versus thrombectomy in acute deep vein thrombosis; Interventional Cardiology 3(5); pp. 589-596; Oct. 2011.
Capture Vascular Systems; (company website); retrieved from the internet: http://www.capturevascular.com; 3 pgs.; retrieved/printed: Mar. 24, 2016.
Edwards Lifesciences; Fogarty® Occlusion Catheters (product brochure); retrieved from the internet: http://web.archive.org/web/20150228193218/http://www.edwards.com/products/vascular/atraumaticocclusion/pages/occlusioncatheter.aspx; ©2011; 2 pgs.; retrieved/printed: Mar. 24, 2011.
Boston Scientific; Fetch(TM) 2 Aspiration Catheter (product information);retrieved from the internet: http://www.bostonscientific.com/en-US/products/thrombectomy-systems/fetch2-aspiration-catheter.html; 2 pgs.; retrieved/printed: Mar. 24, 2016.
Penumbra, Inc.; Indigo® System (product information); retrieved from the internet: http://www.penumbrainc.com/peripherallpercutaneous-thromboembolectomy/indigo-system; 7 pgs.; retrieved/printed: Mar. 24, 2016.
Youtube; Merci Retrieval System X Series Animation; uploaded Mar. 16, 2009 (product information); posted on May 7, 2009 by SSMDePAUL, time 1:09, retrieved from the internet: https://www.youtube.com/watch?v=MGX7deuFkhc; 3 pgs.; retrieved/printed: Mar. 24, 2016.
COVIDIEN; Solitaire(TM) AS Neurovascular Remodeling Device (product information); retrieved from the internet: http://www.ev3.net/neuro/intl/remodeling-devices/solitaire-ab. htm; © 2015; 2 pgs.; retrieved/printed: Mar. 24, 2016.
PCT International Search Report and Written Opinion for International Patent Appln. No. PCT/US2019/050467, Applicant Stryker Corporation, dated Dec. 18, 2019 (17 pages).
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2017/029440, Applicant Stryker Corporation, dated Jul. 7, 2017.
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2017/029472, Applicant Stryker Corporation, dated Jul. 7, 2017.
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2017/035543, Applicant Stryker Corporation, dated Aug. 14, 2017.
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2017/029366, Applicant Stryker Corporation, dated Aug. 29, 2017.
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2017/050933, Applicant Stryker Corporation, forms PCT/ISA/210, 220, and 237, dated Nov. 10, 2017 (16 pages).
International search report and written opinion dated Feb. 28, 2018 for PCT/US2017/029345, Applicant Stryker Corporation 26 pages.
Extended European Search Report dated Aug. 22, 2018 for European patent appln No. 16852212.6, 6 pages.
Extended European Search Report dated Oct. 5, 2018 for European patent appln No. 18174891.4, 6 pages.
International search report and written opinion dated Nov. 14, 2018 for PCT/US2018/040937, Applicant Stryker Corporation 16 pages.
International Search Report and Written Opinion dated Mar. 28, 2019 for International Appln. No. PCT/US2018/059607.
International Search Report and Written Opinion dated May 6, 2016 for PCT/US2016/017982.
PCT International Search Report and Written Opinion for International Patent Appln. No. PCT/US2019/032601, Applicant Stryker Corporation, dated Jul. 23, 2019 (12 pages).
Extended European Search Report dated Oct. 8, 2019 for European Patent Application No. 19191925.7.
International Search Report and Written Opinion for International Patent Appln. No. PCT/US2019/050410 dated Oct. 25, 2019.
International Search Report and Written Opinion for International App. No. PCT/US21/35965, Date of Filing: Jun. 4, 2021, Applicant: Inari Medical, Inc., dated Sep. 28, 2021, 12 pages.
International Search Report and Written Opinion for International App. No. PCT/US21/45072 Date of Filing: Aug. 6, 2021, Applicant: Inari Medical, Inc., dated Jan. 20, 2022, 10 pages.
International Search Report and Written Opinion for International App. No. PCT/US21/58793; Date of Filing: Nov. 10, 2021, Applicant: Inari Medical, Inc., dated Mar. 16, 2022, 13 pages.
International Search Report and Written Opinion for International App. No. PCT/US21/59718; Date of Filing: Nov. 17, 2021, Applicant: Inari Medical, Inc., dated Mar. 22, 2022, 13 pages.
International Search Report and Written Opinion for International App. No. PCT/US21/59735; Date of Filing: Nov. 17, 2021, Applicant: Inari Medical, Inc., Date of Mailing: Mar. 22, 2022, 11 pages.

Related Publications (1)

	Number	Date	Country
	20220347455 A1	Nov 2022	US

Provisional Applications (1)

	Number	Date	Country
	62554931	Sep 2017	US

Continuations (3)

	Number	Date	Country
Parent	17705189	Mar 2022	US
Child	17865266		US
Parent	17226318	Apr 2021	US
Child	17705189		US
Parent	16117519	Aug 2018	US
Child	17226318		US

Hemostasis valves and methods of use

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Abstract